# EDGAR Filing Document

**Accession Number:** 0001798100
**File Stem:** 0001628280-25-046456
**Filing Date:** 2025-10
**Character Count:** 233345
**Document Hash:** ee817b73094612a46e6b6892f92cf9e9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-046456.hdr.sgml**: 20251027

**ACCESSION NUMBER**: 0001628280-25-046456

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 107

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251027

**DATE AS OF CHANGE**: 20251027

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NETSTREIT Corp.
- **CENTRAL INDEX KEY:** 0001798100
- **STANDARD INDUSTRIAL CLASSIFICATION:** REAL ESTATE INVESTMENT TRUSTS [6798]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 843356606
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39443
- **FILM NUMBER:** 251420406

**BUSINESS ADDRESS:**
- **STREET 1:** 2021 MCKINNEY AVENUE
- **STREET 2:** SUITE 1150
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201
- **BUSINESS PHONE:** 972-200-7100

**MAIL ADDRESS:**
- **STREET 1:** 2021 MCKINNEY AVENUE
- **STREET 2:** SUITE 1150
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NetSTREIT Corp.
- **DATE OF NAME CHANGE:** 20191227

?xml version='1.0' encoding='ASCII'? ntst-20250930

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

---

| |
|:---|
| **Form 10-Q** |
| **Form 10-Q** |

---

**☒&nbsp;&nbsp;&nbsp;&nbsp;QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended September 30, 2025**

**OR**

**☐&nbsp;&nbsp;&nbsp;&nbsp;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from _____ to _____**

Commission File Number: 001-39443

---

| |
|:---|
| **NETSTREIT Corp.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | | |
|:---|:---|:---|
| **Maryland** | | **84-3356606** |
| (State or other jurisdiction of |  | (I.R.S. Employer |
| incorporation or organization) |  | Identification No.) |
| **2021 McKinney Avenue** <br>**Suite 1150** |  |  |
| **Dallas, Texas** |  | **75201** |
| (Address of principal executive offices) |  | (Zip Code) |
| **(972) 200-7100** | **(972) 200-7100** | **(972) 200-7100** |
| (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) |
| **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** |
| <u>Title of Each Class</u> | <u>Trading Symbol(s)</u> | <u>Name of Each Exchange on Which Registered</u> |
| **Common stock, par value $0.01 per share** | **NTST** | **The New York Stock Exchange** |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares of the issuer's common stock, par value $0.01, outstanding as of October 23, 2025 was 83,561,676.

------

**NETSTREIT CORP. AND SUBSIDIARIES**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **Page** |
| | **<u>[PART I — FINANCIAL INFORMATION](#i058e5e84d872478ab6915372b30916e3_13)</u>** | |
| <u>[Item 1.](#i058e5e84d872478ab6915372b30916e3_16)</u> | <u>[Financial Statements (Unaudited)](#i058e5e84d872478ab6915372b30916e3_16)</u> | <u>[3](#i058e5e84d872478ab6915372b30916e3_16)</u> |
|  | <u>[Condensed Consolidated Balance Sheets as of](#i058e5e84d872478ab6915372b30916e3_19)[September](#i058e5e84d872478ab6915372b30916e3_19)[30, 2025 and December 31, 2024](#i058e5e84d872478ab6915372b30916e3_19)</u> | <u>[3](#i058e5e84d872478ab6915372b30916e3_19)</u> |
|  | <u>[Condensed Consolidated Statements of Operations and Comprehensive](#i058e5e84d872478ab6915372b30916e3_22)[Loss](#i058e5e84d872478ab6915372b30916e3_22)[for the Three and](#i058e5e84d872478ab6915372b30916e3_22)[Nine](#i058e5e84d872478ab6915372b30916e3_22)[Months Ended](#i058e5e84d872478ab6915372b30916e3_22)[September](#i058e5e84d872478ab6915372b30916e3_22)[30, 2025 and 2024](#i058e5e84d872478ab6915372b30916e3_22)</u> | <u>[4](#i058e5e84d872478ab6915372b30916e3_22)</u> |
|  | <u>[Condensed Consolidated Statements of Changes in Equity for the Three and](#i058e5e84d872478ab6915372b30916e3_25)[Nine](#i058e5e84d872478ab6915372b30916e3_25)[Months Ended](#i058e5e84d872478ab6915372b30916e3_25)[September](#i058e5e84d872478ab6915372b30916e3_25)[30, 2025 and 2024](#i058e5e84d872478ab6915372b30916e3_25)</u> | <u>[5](#i058e5e84d872478ab6915372b30916e3_25)</u> |
|  | <u>[Condensed Consolidated Statements of Cash Flows for the](#i058e5e84d872478ab6915372b30916e3_28)[Nine](#i058e5e84d872478ab6915372b30916e3_28)[Months Ended](#i058e5e84d872478ab6915372b30916e3_28)[September](#i058e5e84d872478ab6915372b30916e3_28)[30, 2025 and 2024](#i058e5e84d872478ab6915372b30916e3_28)</u> | <u>[7](#i058e5e84d872478ab6915372b30916e3_28)</u> |
|  | <u>[Notes to the Condensed Consolidated Financial Statements](#i058e5e84d872478ab6915372b30916e3_31)</u> | <u>[8](#i058e5e84d872478ab6915372b30916e3_31)</u> |
| <u>[Item 2.](#i058e5e84d872478ab6915372b30916e3_73)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i058e5e84d872478ab6915372b30916e3_73)</u> | <u>[31](#i058e5e84d872478ab6915372b30916e3_73)</u> |
| <u>[Item 3.](#i058e5e84d872478ab6915372b30916e3_76)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i058e5e84d872478ab6915372b30916e3_76)</u> | <u>[46](#i058e5e84d872478ab6915372b30916e3_76)</u> |
| <u>[Item 4.](#i058e5e84d872478ab6915372b30916e3_79)</u> | <u>[Controls and Procedures](#i058e5e84d872478ab6915372b30916e3_79)</u> | <u>[47](#i058e5e84d872478ab6915372b30916e3_79)</u> |
|  | **<u>[PART II – OTHER INFORMATION](#i058e5e84d872478ab6915372b30916e3_82)</u>** |  |
| <u>[Item 1.](#i058e5e84d872478ab6915372b30916e3_85)</u> | <u>[Legal Proceedings](#i058e5e84d872478ab6915372b30916e3_85)</u> | <u>[48](#i058e5e84d872478ab6915372b30916e3_85)</u> |
| <u>[Item 1A.](#i058e5e84d872478ab6915372b30916e3_88)</u> | <u>[Risk Factors](#i058e5e84d872478ab6915372b30916e3_88)</u> | <u>[48](#i058e5e84d872478ab6915372b30916e3_88)</u> |
| <u>[Item 2.](#i058e5e84d872478ab6915372b30916e3_91)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i058e5e84d872478ab6915372b30916e3_91)</u> | <u>[48](#i058e5e84d872478ab6915372b30916e3_91)</u> |
| <u>[Item 3.](#i058e5e84d872478ab6915372b30916e3_94)</u> | <u>[Defaults Upon Senior Securities](#i058e5e84d872478ab6915372b30916e3_94)</u> | <u>[48](#i058e5e84d872478ab6915372b30916e3_94)</u> |
| <u>[Item 4.](#i058e5e84d872478ab6915372b30916e3_97)</u> | <u>[Mine Safety Disclosures](#i058e5e84d872478ab6915372b30916e3_97)</u> | <u>[48](#i058e5e84d872478ab6915372b30916e3_97)</u> |
| <u>[Item 5.](#i058e5e84d872478ab6915372b30916e3_100)</u> | <u>[Other Information](#i058e5e84d872478ab6915372b30916e3_100)</u> | <u>[48](#i058e5e84d872478ab6915372b30916e3_100)</u> |
| <u>[Item 6.](#i058e5e84d872478ab6915372b30916e3_103)</u> | <u>[Exhibits](#i058e5e84d872478ab6915372b30916e3_103)</u> | <u>[49](#i058e5e84d872478ab6915372b30916e3_103)</u> |
|  | <u>[Signatures](#i058e5e84d872478ab6915372b30916e3_106)</u> | <u>[50](#i058e5e84d872478ab6915372b30916e3_106)</u> |

---

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**PART I — FINANCIAL INFORMATION**

**Item 1. *Financial Statements (unaudited)***

**NETSTREIT CORP. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

(In thousands, except share and per share data)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| **Assets** | | |
| Real estate, at cost: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Land | $676664 | $571272 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buildings and improvements | 1471002 | 1400393 |
| Total real estate, at cost | 2147666 | 1971665 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less accumulated depreciation | (173846) | (143422) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property under development | 1794 | 6118 |
| Real estate held for investment, net | 1975614 | 1834361 |
| Assets held for sale | 86060 | 48637 |
| Mortgage loans receivable, net | 138307 | 139409 |
| Cash, cash equivalents, and restricted cash | 53324 | 14320 |
| Lease intangible assets, net | 157671 | 164392 |
| Other assets, net | 56958 | 58227 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $2467934 | $2259346 |
| **Liabilities and equity** |  |  |
| Liabilities: |  |  |
| Term loans, net | $1092746 | $622608 |
| Revolving credit facility |  | 239000 |
| Mortgage note payable, net | 7824 | 7853 |
| Lease intangible liabilities, net | 17522 | 20177 |
| Liabilities related to assets held for sale | 1954 | 1912 |
| Accounts payable, accrued expenses, and other liabilities | 41957 | 29664 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1162003 | 921214 |
| **Commitments and contingencies (Note 13)** |  |  |
| Equity: |  |  |
| Stockholders' equity |  |  |
| Common stock, $0.01 par value, 400,000,000 shares authorized; 83,479,176 and 81,602,232 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | 835 | 816 |
| Additional paid-in capital | 1540070 | 1507995 |
| Distributions in excess of retained earnings | (235097) | (188046) |
| Accumulated other comprehensive (loss) income | (6619) | 10206 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 1299189 | 1330971 |
| Noncontrolling interests | 6742 | 7161 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | 1305931 | 1338132 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and equity | $2467934 | $2259346 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**NETSTREIT CORP. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS**

(In thousands, except share and per share data)

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Revenues** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Rental revenue (including reimbursable) | $45026 | $38172 | $132774 | $110226 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income on loans receivable | 3282 | 3272 | 9485 | 8458 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other revenue |  |  | 245 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 48308 | 41444 | 142504 | 118684 |
| **Operating expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Property | 4302 | 4494 | 13589 | 12578 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 5128 | 4287 | 15772 | 15266 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 21389 | 20438 | 63818 | 56522 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provisions for impairment | 5493 | 9838 | 13531 | 17336 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction costs | 19 | 26 | 139 | 201 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 36331 | 39083 | 106849 | 101903 |
| **Other (expense) income** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (12636) | (7965) | (36734) | (21749) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain (loss) on sales of real estate, net | 1122 | (132) | 6730 | 874 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on debt extinguishment |  |  | (46) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income (expense), net | 170 | 416 | 46 | (2451) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense, net | (11344) | (7681) | (30004) | (23326) |
| Net income (loss) before income taxes | 633 | (5320) | 5651 | (6545) |
| Income tax expense | (12) | (2) | (41) | (31) |
| **Net income (loss)** | 621 | (5322) | 5610 | (6576) |
| Net income (loss) attributable to noncontrolling interests | 3 | (27) | 29 | (35) |
| **Net income (loss) income attributable to common stockholders** | $618 | $(5295) | $5581 | $(6541) |
| Amounts available to common stockholders per common share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.01 | $(0.07) | $0.07 | $(0.09) |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.01 | $(0.07) | $0.07 | $(0.09) |
| Weighted average common shares: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 83472089 | 77610680 | 82344168 | 74822286 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 85641948 | 77610680 | 83429550 | 74822286 |
| **Other comprehensive loss:** |  |  |  |  |
| Net income (loss) | $621 | $(5322) | $5610 | $(6576) |
| Change in value of derivatives, net | (1404) | (20164) | (16912) | (11456) |
| Total comprehensive loss | $(783) | $(25486) | $(11302) | $(18032) |
| Comprehensive loss attributable to noncontrolling interests | (4) | (138) | (58) | (95) |
| **Comprehensive loss attributable to common stockholders** | $(779) | $(25348) | $(11244) | $(17937) |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**NETSTREIT CORP. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY**

(In thousands, except share data)

(Unaudited)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common stock** | **Common stock** | | | | | | |
| | **Shares** | **Par Value** |<br>**Additional <br>Paid-in Capital** |<br>**Distributions in Excess of Retained Earnings** |<br>**Accumulated Other Comprehensive Income (Loss)** |<br>**Total Stockholders' Equity** |<br>**Noncontrolling Interests** |<br>**Total Equity** |
| **Balance at December 31, 2024** | 81602232 | $816 | $1507995 | $(188046) | $10206 | $1330971 | $7161 | $1338132 |
| Dividends and distributions declared on common stock and OP Units |  |  |  | (17157) |  | (17157) | (89) | (17246) |
| Dividends declared on restricted stock, net |  |  |  | (181) |  | (181) |  | (181) |
| Vesting of restricted stock units | 136338 | 1 | (1) |  |  |  |  |  |
| Repurchase of common stock for tax withholding obligations | (39661) |  | (573) |  |  | (573) |  | (573) |
| Stock-based compensation, net |  |  | 1388 | 169 |  | 1557 |  | 1557 |
| Other comprehensive loss |  |  |  |  | (9813) | (9813) | (51) | (9864) |
| Net income |  |  |  | 1691 |  | 1691 | 9 | 1700 |
| **Balance at March 31, 2025** | 81698909 | $817 | $1508809 | $(203524) | $393 | $1306495 | $7030 | $1313525 |
| Issuance of common stock in public offerings, net of issuance costs | 1757815 | 18 | 28334 |  |  | 28352 |  | 28352 |
| Dividends and distributions declared on common stock and OP Units |  |  |  | (17159) |  | (17159) | (89) | (17248) |
| Dividends declared on restricted stock, net |  |  |  | (178) |  | (178) |  | (178) |
| Vesting of restricted stock units | 13096 |  |  |  |  |  |  |  |
| Repurchase of common stock for tax withholding obligations | (4769) |  | (72) |  |  | (72) |  | (72) |
| Stock-based compensation, net |  |  | 1521 |  |  | 1521 |  | 1521 |
| Other comprehensive loss |  |  |  |  | (5615) | (5615) | (29) | (5644) |
| Net income |  |  |  | 3272 |  | 3272 | 17 | 3289 |
| **Balance at June 30, 2025** | 83465051 | $835 | $1538592 | $(217589) | $(5222) | $1316616 | $6929 | $1323545 |
| OP Units converted to common stock | 5694 |  | 92 |  |  | 92 | (92) |  |
| Dividends and distributions declared on common stock and OP Units |  |  |  | (17947) |  | (17947) | (91) | (18038) |
| Dividends declared on restricted stock, net |  |  |  | (179) |  | (179) |  | (179) |
| Vesting of restricted stock units | 13678 |  |  |  |  |  |  |  |
| Repurchase of common stock for tax withholding obligations | (5247) |  | (98) |  |  | (98) |  | (98) |
| Stock-based compensation, net |  |  | 1484 |  |  | 1484 |  | 1484 |
| Other comprehensive loss |  |  |  |  | (1397) | (1397) | (7) | (1404) |
| Net income |  |  |  | 618 |  | 618 | 3 | 621 |
| **Balance at September 30, 2025** | 83479176 | $835 | $1540070 | $(235097) | $(6619) | $1299189 | $6742 | $1305931 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**NETSTREIT CORP. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY**

(In thousands, except share data)

(Unaudited)

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common stock** | **Common stock** | | | | | | |
| | **Shares** | **Par Value** |<br>**Additional <br>Paid-in Capital** |<br>**Distributions in Excess of Retained Earnings** |<br>**Accumulated Other Comprehensive Income (Loss)** |<br>**Total Stockholders' Equity** |<br>**Noncontrolling Interests** |<br>**Total Equity** |
| **Balance at December 31, 2023** | 73207080 | $732 | $1367505 | $(112276) | $8943 | $1264904 | $8528 | $1273432 |
| OP Units converted to common stock | 7119 |  | 126 |  |  | 126 | (126) |  |
| Dividends and distributions declared on common stock and OP Units |  |  |  | (15031) |  | (15031) | (98) | (15129) |
| Dividends declared on restricted stock, net |  |  |  | (143) |  | (143) |  | (143) |
| Vesting of restricted stock units | 176197 | 2 | (2) |  |  |  |  |  |
| Repurchase of common stock for tax withholding obligations | (61985) | (1) | (1068) |  |  | (1069) |  | (1069) |
| Stock-based compensation, net |  |  | 1751 | 135 |  | 1886 |  | 1886 |
| Other comprehensive income |  |  |  |  | 9077 | 9077 | 51 | 9128 |
| Net income |  |  |  | 1045 |  | 1045 | 7 | 1052 |
| **Balance at March 31, 2024** | 73328411 | $733 | $1368312 | $(126270) | $18020 | $1260795 | $8362 | $1269157 |
| Issuance of common stock in public offerings, net of issuance costs | 4000000 | 40 | 65284 |  |  | 65324 |  | 65324 |
| OP Units converted to common stock | 35121 |  | 611 |  |  | 611 | (611) |  |
| Dividends and distributions declared on common stock and OP Units |  |  |  | (15042) |  | (15042) | (90) | (15132) |
| Dividends declared on restricted stock, net |  |  |  | (139) |  | (139) |  | (139) |
| Vesting of restricted stock units | 23510 |  |  |  |  |  |  |  |
| Repurchase of common stock for tax withholding obligations | (9363) |  | (160) |  |  | (160) |  | (160) |
| Stock-based compensation, net |  |  | 1530 | 8 |  | 1538 |  | 1538 |
| Other comprehensive loss |  |  |  |  | (420) | (420) |  | (420) |
| Net loss |  |  |  | (2291) |  | (2291) | (15) | (2306) |
| **Balance at June 30, 2024** | 77377679 | $773 | $1435577 | $(143734) | $17600 | $1310216 | $7646 | $1317862 |
| Issuance of common stock in public offerings, net of issuance costs | 4183711 | 43 | 70109 |  |  | 70152 |  | 70152 |
| OP Units converted to common stock | 12102 |  | 204 |  |  | 204 | (204) |  |
| Dividends and distributions declared on common stock and OP Units |  |  |  | (16251) |  | (16251) | (92) | (16343) |
| Dividends declared on restricted stock, net |  |  |  | (141) |  | (141) |  | (141) |
| Vesting of restricted stock units | 16455 |  |  |  |  |  |  |  |
| Repurchase of common stock for tax withholding obligations | (6030) |  | (96) |  |  | (96) |  | (96) |
| Stock-based compensation, net |  |  | 1376 |  |  | 1376 |  | 1376 |
| Other comprehensive loss |  |  |  |  | (20053) | (20053) | (111) | (20164) |
| Net loss |  |  |  | (5295) |  | (5295) | (27) | (5322) |
| **Balance at September 30, 2024** | 81583917 | $816 | $1507170 | $(165421) | $(2453) | $1340112 | $7212 | $1347324 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**NETSTREIT CORP. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

(In thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| **Cash flows from operating activities** |  |  |
| Net income (loss) | $5610 | $(6576) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 63818 | 56522 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred financing costs | 2164 | 1673 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of above/below-market assumed debt | 86 | 86 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noncash revenue adjustments | (3473) | (2378) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred losses (gains) on interest rate swaps | 2138 | (2948) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 4393 | 4657 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sales of real estate, net | (6730) | (874) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions for impairment | 13531 | 17336 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on debt extinguishment | 46 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on involuntary conversion of building and improvements | (45) | 644 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities, net of assets acquired and liabilities assumed: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets, net | (775) | (4019) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, accrued expenses, and other liabilities | 402 | (1973) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lease incentive payments | (464) | (22) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 80701 | 62128 |
| **Cash flows from investing activities** |  |  |
| &nbsp;&nbsp;Acquisitions of real estate | (365223) | (302299) |
| &nbsp;&nbsp;Real estate development and improvements | (4041) | (37306) |
| &nbsp;&nbsp;Investment in mortgage loans receivable | (26726) | (26205) |
| &nbsp;&nbsp;Earnest money deposits | (382) | (7925) |
| &nbsp;&nbsp;Purchase of computer equipment and other corporate assets | (35) | (8) |
| &nbsp;&nbsp;Proceeds from sale of real estate | 121719 | 42845 |
| &nbsp;&nbsp;Principal collections on mortgage loans receivable | 24655 | 11258 |
| &nbsp;&nbsp;Proceeds from sale of mortgage loans receivable | 10480 |  |
| &nbsp;&nbsp;Proceeds from the settlement of property-related insurance claims | 45 | 261 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (239508) | (319379) |
| **Cash flows from financing activities** |  |  |
| &nbsp;&nbsp;Issuance of common stock in public offerings, net | 28352 | 135475 |
| &nbsp;&nbsp;Payment of common stock dividends | (52263) | (46324) |
| &nbsp;&nbsp;Payment of OP unit distributions | (269) | (280) |
| &nbsp;&nbsp;Payment of restricted stock dividends | (274) | (491) |
| &nbsp;&nbsp;Principal payments on mortgages payable | (122) | (115) |
| &nbsp;&nbsp;Proceeds under revolving credit facilities | 199000 | 251000 |
| &nbsp;&nbsp;Repayments under revolving credit facilities | (438000) | (181000) |
| &nbsp;&nbsp;Proceeds from term loans | 518675 | 100000 |
| &nbsp;&nbsp;Principal payments on term loans | (43675) |  |
| &nbsp;&nbsp;Repurchase of common stock for tax withholding obligations | (743) | (1325) |
| &nbsp;&nbsp;Payment of deferred offering costs | (835) | (868) |
| &nbsp;&nbsp;Payment of deferred financing costs | (12035) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 197811 | 256072 |
| Net change in cash, cash equivalents, and restricted cash | 39004 | (1179) |
| Cash, cash equivalents, and restricted cash at beginning of the period | 14320 | 29929 |
| Cash, cash equivalents, and restricted cash at end of the period | $53324 | $28750 |
| Supplemental disclosures of cash flow information: |  |  |
| &nbsp;&nbsp;Cash paid for interest, net of amounts capitalized | $31894 | $22778 |
| &nbsp;&nbsp;Cash (received) paid for income taxes, net | $(3) | $27 |
| Supplemental disclosures of non-cash investing and financing activities: |  |  |
| &nbsp;&nbsp;Dividends declared and unpaid on restricted stock | $368 | $279 |
| &nbsp;&nbsp;Deferred offering costs included in accounts payable, accrued expenses, and other liabilities | $16 | $318 |
| &nbsp;&nbsp;Accrued loan origination fees on mortgage loans receivable | $188 | $200 |
| &nbsp;&nbsp;Cash flow hedge change in fair value | $(19050) | $(8508) |
| &nbsp;&nbsp;Increase in mortgage loan receivable in exchange for disposition of real estate | $8450 | $12714 |
| &nbsp;&nbsp;Assumption of tenant allowances, other liabilities, and settlement of receivables in acquisitions of real estate | $3068 | $1007 |
| &nbsp;&nbsp;Accrued capital expenditures and real estate development and improvement costs | $2025 | $3963 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**NETSTREIT CORP. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Unaudited)

**Note 1 – Organization and Description of Business**

NETSTREIT Corp. (the "Company") was incorporated on October 11, 2019 as a Maryland corporation and commenced operations on December 23, 2019. The Company conducts its operations through NETSTREIT, L.P., a Delaware limited partnership (the "Operating Partnership"). NETSTREIT GP, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company, is the sole general partner of the Operating Partnership.

The Company elected to be treated as and to qualify as a real estate investment trust ("REIT") for U.S. federal income tax purposes beginning with its short taxable year ended December 31, 2019. Additionally, the Operating Partnership formed NETSTREIT Management TRS, LLC ("NETSTREIT TRS"), which together with the Company jointly elected to be treated as a taxable REIT subsidiary under Section 856(a) of the Internal Revenue Code of 1986, as amended, (the "Code") for U.S. federal income tax purposes.

The Company is structured as an umbrella partnership real estate investment trust (commonly referred to as an "UPREIT") and is an internally managed real estate company that acquires, owns, and manages a diversified portfolio of single-tenant commercial retail properties, subject to long-term net leases with high-credit-quality tenants across the United States. The Company also invests in property developments and mortgage loans secured by real estate. As of September 30, 2025, the Company owned or had investments in 723 properties located in 45 states.

**Note 2 – Summary of Significant Accounting Policies** 

**Basis of Presentation**

The accompanying interim condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") and the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). The accompanying condensed consolidated financial statements include the accounts of the Company and subsidiaries in which the Company has a controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation and the Company's net income (loss) is reduced by the portion of net income (loss) attributable to noncontrolling interests.

**Interim Unaudited Financial Information**

The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC. These unaudited interim condensed consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements, and should be read in conjunction with the Company's audited consolidated financial statements and notes thereto on the Annual Report on Form 10-K as of and for the year ended December 31, 2024, which provide a more complete understanding of the Company's accounting policies, financial position, operating results, business properties, and other matters. In the opinion of management, all adjustments of a normal recurring nature necessary for a fair presentation have been included. The results of operations for the three and nine months ended September 30, 2025 and 2024 are not necessarily indicative of the results for the full year.

**Use of Estimates**

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company's most significant assumptions and estimates relate to the useful lives of real estate assets, lease accounting, real estate impairment assessments, and allocation of fair value of purchase consideration. These estimates are based on historical experience and other assumptions which management believes are reasonable under the circumstances. The Company evaluates its estimates on an ongoing basis and makes revisions to these estimates and related disclosures as experience develops or new information becomes known. Actual results could differ from those estimates.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**Provisions for Impairment**

*Long-Lived Assets*

Fair value measurement of an asset group occurs when events or changes in circumstances related to an asset indicate that the carrying amount of the asset is no longer recoverable. An example of an event or changed circumstance is a reduction in the expected holding period of a property. If indicators are present, the Company will prepare a projection of the undiscounted future cash flows of the property, excluding interest charges, and determine if the carrying amount of the asset group is recoverable. When a carrying amount is not recoverable, an impairment loss is recognized to the extent that the carrying amount of the asset group exceeds its fair market value. The Company estimates fair value using data such as operating income, estimated capitalization rates or multiples, leasing prospects, local market information, and discount rates, and with regard to assets held for sale, based on the estimated or negotiated selling price, less estimated costs of disposal. Based on these unobservable inputs, the Company determined that its valuations of impaired real estate and intangible assets fall within Level 3 of the fair value hierarchy under Accounting Standards Codification ("ASC") Topic 820. The Company recorded provisions for impairment on long-lived assets of $4.1 million and $9.8 million during the three months ended September 30, 2025 and 2024, respectively, and $12.2 million and $17.3 million during the nine months ended September 30, 2025 and 2024, respectively.

*Mortgage Loans Receivable, Net*

The Company classifies mortgage loans receivable as held for sale when it has made the decision to sell a loan. The Company records provisions for impairment on mortgage loans receivable when classified as held for sale if the amortized cost basis exceeds fair value. Fair value is determined based on Level 3 inputs within the fair value hierarchy under ASC 820, which includes the expected selling price of the loan, current market conditions, investor yield requirements, and other relevant factors. The Company recorded non-credit related provisions for impairment of $1.4 million on three mortgage loans receivable that were disposed of at a discount during the three and nine months ended September 30, 2025. No provisions for impairment on mortgage loans receivable were recorded during the three and nine months ended September 30, 2024.

**Cash, Cash Equivalents, and Restricted Cash**

The Company considers all cash balances, money market accounts, and highly liquid investments with original maturities of three months or less to be cash and cash equivalents. Restricted cash includes cash restricted for property tenant improvements and cash proceeds from the sale of assets held by qualified intermediaries in anticipation of the acquisition of replacement properties in tax-free exchanges under Section 1031 of the Code. Restricted cash is included in cash, cash equivalents, and restricted cash in the condensed consolidated balance sheets. The Company had no restricted cash as of September 30, 2025 and $7.9 million of restricted cash as of December 31, 2024.

The Company's bank balances as of September 30, 2025 and December 31, 2024 included certain amounts over the Federal Deposit Insurance Corporation limits.

**Fair Value Measurements**

The Company estimates fair value of financial and nonfinancial assets and liabilities based on the framework established in the fair value accounting guidance, ASC Topic 820, Fair Value Measurement. Fair value measurements are utilized in the accounting of the Company's assets acquired and liabilities assumed in an asset acquisition and also affect the Company's accounting for certain of its financial assets and liabilities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The hierarchy described below prioritizes inputs to the valuation techniques used in measuring the fair value of assets and liabilities. This hierarchy maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs to be used when available. The hierarchy is broken down into three levels based on the reliability of inputs as follows:

Level 1 — Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.

Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3 — Unobservable inputs for the asset or liability.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**Concentrations of Credit Risk**

During the three and nine months ended September 30, 2025, there were no tenants or borrowers with rental revenue or interest income on loans receivable that exceeded 10% of total revenues.

During the three and nine months ended September 30, 2024, one tenant, Dollar General, accounted for 11.6% and 12.0% of total revenues, respectively.

Other financial instruments that potentially subject the Company to significant concentrations of credit risk consist of cash held at various financial institutions, access to the Company's credit facilities, and amounts due or payable under derivative contracts. These credit risk exposures are spread among a diversified group of investment grade financial institutions.

**Segment Reporting**

ASC Topic 280, Segment Reporting, establishes standards for the manner in which companies report information about operating segments. The Company is an internally managed real estate company that acquires, owns, invests in, and manages a diversified portfolio of single-tenant commercial retail properties, subject to long-term net leases with high-credit-quality tenants across the United States. The Company primarily engages in leasing activities that generate revenues and incur operating expenses in addition to investing in property developments and mortgage loans secured by real estate. The Company aggregates these investments for reporting purposes and operates in one reportable segment.

The Company's chief operating decision maker ("CODM") is the Company's senior executive investment committee that includes the chief executive officer and chief financial officer. The CODM uses net income (loss), as reported on the condensed consolidated statements of operations and comprehensive loss to measure segment operating performance and allocate resources. All of the Company's expenses are included in segment operating performance and are reviewed regularly. Significant segment expenses include property, general and administrative, depreciation and amortization, provisions for impairment, and interest expense. The measure of segment assets is reported on the Company's condensed consolidated balance sheets as total assets. The CODM also reviews characteristics of potential future investments such as weighted average remaining lease term ("WALT"), capitalization rate, tenant credit quality, industry type, and geographic location.

**Recent Accounting Pronouncements**

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"). ASU 2023-09 requires annual disclosure of specific categories in the rate reconciliation and provides additional information for reconciling items that meet a quantitative threshold within the rate reconciliation. In addition, the amendments require annual disclosure of income taxes paid disaggregated by federal, state, and foreign jurisdictions as well as individual jurisdictions in which income taxes paid is equal to or greater than five percent of total income taxes paid. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 on a prospective basis, however early adoption and retrospective application is permitted. The Company is currently evaluating the potential impact of the guidance and potential additional disclosures required.

In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03"). ASU 2024-03 requires disclosure, in the notes to the financial statements, of specified information about certain costs and expenses and a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is currently evaluating the potential impact of the guidance and potential additional disclosures required.

**Note 3 – Leases**

*Tenant Leases*

The Company acquires, owns, and manages single-tenant commercial retail net lease properties, the majority of which have long-term triple-net leases where the tenant is generally responsible for all improvements and contractually obligated to pay all operating costs (such as real estate taxes, utilities, and repairs and maintenance costs). As of September 30, 2025, exclusive of mortgage loans receivable, the Company's WALT was 9.9 years.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

The Company's property leases have been classified as operating leases, most of which have scheduled rent increases throughout the lease term. The Company's leases typically provide the tenant one or more multi-year renewal options to extend their leases, subject to generally the same terms and conditions, including rent increases, consistent with the initial lease term.

All lease-related income is reported as a single line item, rental revenue (including reimbursable), in the condensed consolidated statements of operations and comprehensive loss and is presented net of any reserves, write-offs, or recoveries for uncollectible amounts.

Fixed lease income includes stated amounts per the lease contract, which include base rent, fixed common area maintenance charges, and straight-line lease adjustments.

Variable lease income primarily includes recoveries from tenants, which represent amounts that tenants are contractually obligated to reimburse the Company for, specific to their portion of actual recoverable costs incurred. Variable lease income also includes percentage rent, which represents amounts billable to tenants based on their actual sales volume in excess of levels specified in the lease contract.

The following table provides a disaggregation of lease income recognized under ASC 842 (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Rental revenue |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed lease income <sup>(1)</sup> | $41587 | $35346 | $121854 | $101000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Variable lease income <sup>(2)</sup> | 3404 | 2657 | 10809 | 8864 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other rental revenue: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Above/below market lease amortization, net | 247 | 354 | 766 | 927 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lease incentives | (212) | (185) | (655) | (565) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rental revenue (including reimbursable) | $45026 | $38172 | $132774 | $110226 |

---

<sup>(1)&nbsp;&nbsp;&nbsp;&nbsp;</sup>Fixed lease income includes contractual rents under lease agreements with tenants recognized on a straight-line basis over the lease term.

<sup>(2)&nbsp;&nbsp;&nbsp;&nbsp;</sup>Variable lease income primarily includes tenant reimbursements for real estate taxes, insurance, common area maintenance, and reserves for uncollectible amounts. There were no material reserves, write-offs, or recoveries of uncollectible amounts during the three and nine months ended September 30, 2025 and 2024.

Scheduled future minimum base rental payments (excluding base rental payments from properties classified as held for sale and straight-line rent adjustments for all properties) due to be received under the remaining noncancellable term of the operating leases in place as of September 30, 2025 are as follows (in thousands):

---

| | |
|:---|:---|
| | **Future Minimum Base<br>Rental Receipts** |
| Remainder of 2025 | $41230 |
| 2026 | 165266 |
| 2027 | 163299 |
| 2028 | 158233 |
| 2029 | 149465 |
| Thereafter | 1065458 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $1742951 |

---

Future minimum rentals exclude amounts that may be received from tenants for reimbursements of operating costs and property taxes. In addition, the future minimum rents do not include any contingent rents based on a percentage of the lessees' gross sales or lease escalations based on future changes in the Consumer Price Index or other stipulated reference rate.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**Note 4 – Real Estate Investments**

As of September 30, 2025, the Company owned or had investments in 723 properties. The gross real estate investment portfolio, including properties under development and mortgage loans receivable, totaled approximately $2.6 billion and consisted of the gross acquisition cost of land, buildings, improvements, lease intangible assets and liabilities, mortgage loans receivable, and property development costs. The investment portfolio is geographically dispersed throughout 45 states with gross real estate investments in Texas and Illinois representing 14.6% and 8.4%, respectively, of the total gross real estate investment of the Company's investment portfolio.

The Company's gross investment portfolio as of September 30, 2025 and December 31, 2024 is summarized below (dollars in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Number of Investments** | **Number of Investments** | **Amount of Investment** | **Amount of Investment** |
| | **September 30, 2025** | **December 31, 2024** | **September 30, 2025** | **December 31, 2024** |
| Properties held for investment <sup>(1)</sup> | 602 | 589 | $2349144 | $2164566 |
| Properties held for sale | 39 | 23 | 84106 | 46725 |
| Mortgage loans receivable | 80 | 76 | 138452 | 139483 |
| Properties under development <sup>(2)</sup> | 2 | 4 | 1794 | 6118 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total gross investment | 723 | 692 | $2573496 | $2356892 |

---

<sup>(1)</sup> Includes one vacant property for the periods ended September 30, 2025 and December 31, 2024, and one completed development where rent had not commenced as of December 31, 2024.

<sup>(2)</sup> Rent has not commenced for properties under development.

*Acquisitions* 

*&nbsp;&nbsp;&nbsp;&nbsp;*

The Company's acquisitions during the three and nine months ended September 30, 2025 and 2024 were all accounted for as asset acquisitions. An allocation of the purchase price and acquisition costs paid for the completed acquisitions during the period is as follows (dollars in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Number of properties acquired | 46 | 22 | 87 | 68 |
| Purchase price allocation: |  |  |  |  |
| Land | $76421 | $31964 | $151504 | $76836 |
| Buildings | 93726 | 64504 | 173046 | 179391 |
| Site improvements | 9363 | 5792 | 16444 | 19221 |
| Tenant improvements | 1263 | 801 | 2112 | 2605 |
| In-place lease intangible assets | 12619 | 9481 | 24288 | 25253 |
| Above-market lease intangible assets | 968 |  | 968 |  |
| Below-market lease intangible liabilities | (71) |  | (71) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total <sup>(1)</sup> | $194289 | $112542 | $368291 | $303306 |

---

<sup>(1)</sup> During the three months ended September 30, 2025 and 2024, the Company capitalized $2.3 million and $1.1 million of acquisition costs, respectively. During the nine months ended September 30, 2025 and 2024, the Company capitalized $4.2 million and $2.8 million of acquisition costs, respectively.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

*Dispositions*

The Company's property dispositions during the three and nine months ended September 30, 2025 and 2024 are summarized below (dollars in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Number of properties sold | 24 | 8 | 60 | 26 |
| Sales price, net of disposal costs | $35993 | $23018 | $130169 | $55559 |
| Gain (loss) on sales of real estate, net | $1122 | $(132) | $6730 | $874 |

---

*Development*

The Company's investment in property developments during the three and nine months ended September 30, 2025 and 2024 are summarized below (dollars in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Number of developments acquired |  |  |  | 4 |
| Purchase price of acquired developments | $— | $— | $— | $2010 |
| Total investment in properties under development <sup>(1)</sup> | $14 | $4975 | $2214 | $27936 |
| Number of developments completed <sup>(2)</sup> |  | 2 | 2 | 16 |
| Amounts placed into service <sup>(3)</sup> | $— | $12529 | $6545 | $47772 |

---

<sup>(1)</sup> During the three months ended September 30, 2025 and 2024, the Company capitalized less than $0.1 million and $0.1 million, respectively, of interest expense associated with properties under development. During the nine months ended September 30, 2025 and 2024, the Company capitalized approximately $0.1 million and $0.7 million, respectively, of interest expense associated with properties under development.

<sup>(2)</sup> For the two developments completed during the nine months ended September 30, 2025, rent commenced in the second quarter of 2025. For the 16 developments completed during the nine months ended September 30, 2024, rent commenced at various points throughout 2024.

<sup>(3)</sup> Amounts reclassified from property under development to land, buildings and improvements, and other assets (leasing commissions) in the accompanying condensed consolidated balance sheets.

As of September 30, 2025, the Company had two property developments under construction, which are expected to be substantially completed with rent commencing at various points throughout 2026. The purchase price, including acquisition costs, and subsequent development are included in property under development in the accompanying condensed consolidated balance sheets as of September 30, 2025.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

*Investment in Mortgage Loans Receivable*

The Company's mortgage loans receivable portfolio as of September 30, 2025 and December 31, 2024 is summarized below (dollars in thousands):

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Loan Type** | **Monthly Payment** <sup>(1)</sup> | **Number of Secured Properties** | **Effective Interest Rate** <sup>(2)</sup> | **Stated Interest Rate** | **Maturity Date** | **September 30, 2025** | **December 31, 2024** |
| Mortgage <sup>(3) (4)</sup> | I/O | 1 | 6.94% | 6.00% | 8/31/2027 | $38162 | $43612 |
| Mortgage <sup>(4)</sup> | I/O | 46 | 9.55% | 9.55% | 3/10/2026 | 41940 | 41940 |
| Mortgage <sup>(4) (5)</sup> | I/O | 3 | 8.10% | 6.89% | 4/10/2026 | 4132 | 4132 |
| Mortgage <sup>(3) (4) (5)</sup> | I/O | 2 | 8.79% | 10.09% | 6/10/2026 | 2230 | 8408 |
| Mortgage | None <sup>(6)</sup> | 1 | 7.00% | 7.00% | 1/31/2026 | 825 | 825 |
| Mortgage <sup>(3) (4) (7)</sup> | I/O | 6 | 10.26% | 10.25% | 2/22/2026 | 11059 | 11658 |
| Mortgage <sup>(3) (4) (8)</sup> | I/O | 5 | 10.25% | 10.25% | 2/27/2026 | 10174 | 8853 |
| Mortgage <sup>(9)</sup> | P+I | 1 | 7.25% | 7.25% | 7/17/2027 |  | 4076 |
| Mortgage <sup>(9)</sup> | P+I | 1 | 7.25% | 7.25% | 7/17/2027 |  | 5221 |
| Mortgage | I/O | 1 | 14.68% | 13.09% | 1/17/2025 |  | 1299 |
| Mortgage | P+I | 1 | 7.25% | 7.25% | 9/19/2027 | 1416 | 1434 |
| Mortgage | I/O | 1 | 7.00% | 7.00% | 9/30/2029 | 636 | 636 |
| Mortgage | I/O | 1 | 6.50% | 6.50% | 12/23/2029 | 3284 | 3284 |
| Mortgage | I/O | 1 | 6.50% | 6.50% | 12/23/2029 | 4105 | 4105 |
| Mortgage <sup>(3) (4)</sup> | I/O | 1 | 9.75% | 9.75% | 3/12/2026 | 1533 |  |
| Mortgage <sup>(3) (4) (10)</sup> | None <sup>(6)</sup> | 10 | 9.75% | 9.75% | 10/30/2026 | 12906 |  |
| Mortgage | I/O | 1 | 7.25% | 7.25% | 5/18/2027 | 6050 |  |
| &nbsp;&nbsp;Total |  |  |  |  |  | $138452 | $139483 |
| Unamortized loan origination costs and fees, net | Unamortized loan origination costs and fees, net | Unamortized loan origination costs and fees, net |  |  |  | 55 | 74 |
| Unamortized discount | Unamortized discount | Unamortized discount |  |  |  | (200) | (148) |
| &nbsp;&nbsp;Total mortgage loans receivable, net | &nbsp;&nbsp;Total mortgage loans receivable, net | &nbsp;&nbsp;Total mortgage loans receivable, net |  |  |  | $138307 | $139409 |

---

<sup>(1)</sup> I/O: Interest Only; P+I: Principal and Interest.

<sup>(2)</sup> Includes amortization of discount, loan origination costs and fees, as applicable.

<sup>(3)</sup> The Company has the right, subject to certain terms and conditions, to acquire all or a portion of the underlying collateralized properties.

<sup>(4)</sup> Loans require monthly payments of interest only with principal payments occurring as borrower disposes of underlying properties, limited to the Company's allocated investment by property. Any remaining principal balance will be repaid at or before the maturity date.

<sup>(5)</sup> The stated interest rate is variable up to 15.0% and is calculated based on contractual rent for existing collateralized properties subject to the loan agreement.

<sup>(6)</sup> Payments of both interest and principal are due at maturity.

<sup>(7)</sup> The collateralized properties are in process developments with varying maturity dates dependent upon initial funding. Maturity dates range from December 4, 2025 to February 22, 2026.

<sup>(8)</sup> The collateralized properties are in process developments with varying maturity dates dependent upon initial funding. Maturity dates range from October 26, 2025 to February 27, 2026.

<sup>(9)</sup> Loans were disposed during the three and nine months ended September 30, 2025. The table also excludes one loan that was entered into during 2025 and disposed of during the three and nine months ended September 30, 2025.

<sup>(10)</sup> The collateralized properties are in process developments with varying maturity dates dependent upon initial funding. Maturity dates range from March 28, 2026 to October 30, 2026.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**Note 5 – Intangible Assets and Liabilities**

Intangible assets and liabilities consisted of the following (in thousands):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| | **Gross <br>Carrying <br>Amount** | **Accumulated Amortization** | **Net Carrying Amount** | **Gross <br>Carrying <br>Amount** | **Accumulated Amortization** | **Net Carrying Amount** |
| Assets: |  |  |  |  |  |  |
| In-place leases | $210340 | $(72025) | $138315 | $203104 | $(60729) | $142375 |
| Above-market leases | 19765 | (6178) | 13587 | 19644 | (5500) | 14144 |
| Lease incentives | 7825 | (2056) | 5769 | 9529 | (1656) | 7873 |
| Total intangible assets | $237930 | $(80259) | $157671 | $232277 | $(67885) | $164392 |
| Liabilities: |  |  |  |  |  |  |
| Below-market leases | $28627 | $(11105) | $17522 | $29847 | $(9670) | $20177 |

---

The remaining weighted average amortization period for the Company's intangible assets and liabilities as of September 30, 2025 and as of December 31, 2024 by category were as follows:

---

| | | |
|:---|:---|:---|
| | **Years Remaining** | **Years Remaining** |
| | **September 30, 2025** | **December 31, 2024** |
| In-place leases | 8.6 | 8.6 |
| Above-market leases | 11.5 | 11.4 |
| Below-market leases | 9.6 | 10.1 |
| Lease incentives | 8.8 | 10.1 |

---

The Company records amortization of in-place lease assets to amortization expense, and records net amortization of above-market and below-market lease intangibles as well as amortization of lease incentives to rental revenue. The following amounts in the accompanying condensed consolidated statements of operations and comprehensive loss related to the amortization of intangible assets and liabilities for all property and ground leases (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Amortization: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of in-place leases | $5658 | $5588 | $16875 | $15659 |
| Net adjustment to rental revenue: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Above-market lease assets | (371) | (410) | (1122) | (1239) |
| &nbsp;&nbsp;&nbsp;&nbsp;Below-market lease liabilities | 618 | 765 | 1887 | 2167 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lease incentives | (212) | (185) | (655) | (565) |
|  | $35 | $170 | $110 | $363 |

---

The following table provides the projected amortization of in-place lease assets to amortization expense and the net amortization of above-market, below-market, and lease incentive lease intangible assets and liabilities to rental revenue as of September 30, 2025, for the next five years and thereafter (in thousands):

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Remainder of 2025** | **2026** | **2027** | **2028** | **2029** | **Thereafter** | **Total** |
| In-place leases | $5780 | $22286 | $20547 | $17825 | $15410 | $56467 | $138315 |
| Above-market lease assets | $(372) | $(1464) | $(1413) | $(1382) | $(1233) | $(7723) | $(13587) |
| Below-market lease liabilities | 612 | 2368 | 2298 | 2171 | 1990 | 8083 | 17522 |
| Lease incentives | (194) | (776) | (720) | (690) | (652) | (2737) | (5769) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net adjustment to rental revenue | $46 | $128 | $165 | $99 | $105 | $(2377) | $(1834) |

---

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**Note 6 – Debt**

Debt consists of the following (in thousands):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | | | **Amounts Outstanding as of** | **Amounts Outstanding as of** |
| |<br>**Contractual Maturity Date** |<br>**Fully Extended Maturity Date** <sup>(1)</sup> |<br>**Interest Rate** <sup>(2)</sup> |<br>**Hedged Interest Rate** <sup>(3)</sup> | **September 30, 2025** | **December 31, 2024** |
| Debt: |  |  |  |  |  |  |
| &nbsp;&nbsp;2028 Term Loan | February 11, 2028 |  | 5.43% | 3.78% | $200000 | $200000 |
| &nbsp;&nbsp;2029 Term Loan | July 3, 2026 | January 3, 2029 | 5.31% | 4.89% | 250000 | 250000 |
| &nbsp;&nbsp;2030 Term Loan A | January 15, 2029 | January 15, 2030 | 5.27% | 3.55% | 175000 | 175000 |
| &nbsp;&nbsp;2030 Term Loan B | January 15, 2029 | January 15, 2030 | 5.33% | 5.02% | 175000 |  |
| &nbsp;&nbsp;2031 Term Loan | March 25, 2031 |  | 5.33% | 4.59% | 200000 |  |
| &nbsp;&nbsp;2032 Term Loan | September 24, 2032 |  | 5.68% | 4.95% | 100000 |  |
| &nbsp;&nbsp;Revolver | January 15, 2029 | January 15, 2030 | 5.18% |  |  | 239000 |
| &nbsp;&nbsp;Mortgage Note | November 1, 2027 |  | 4.53% |  | 8084 | 8205 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt |  |  |  |  | 1108084 | 872205 |
| Unamortized discount and debt issuance costs | Unamortized discount and debt issuance costs |  |  |  | (7514) | (2744) |
| Unamortized deferred financing costs, net <sup>(4)</sup> | Unamortized deferred financing costs, net <sup>(4)</sup> |  |  |  | (3958) | (1200) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt, net |  |  |  |  | $1096612 | $868261 |

---

<sup>(1)</sup> Date represents the fully extended maturity date available to the Company, subject to certain conditions, under each related debt instrument.

<sup>(2)</sup> Represents the stated interest rate within the respective debt agreement as of September 30, 2025. The term loans and Revolver bear a floating interest rate (SOFR) plus the applicable margin as described further in "Note 6 – Debt".

<sup>(3)</sup> Represents the weighted-average hedged fixed rate plus the applicable margin as of September 30, 2025, as described further in "Note 6 – Debt" and "Note 7 – Derivative Financial Instruments."

<sup>(4)</sup> The Company records deferred financing costs associated with the Revolver in other assets, net in its condensed consolidated balance sheets. The Company reclassified the net amount of loan commitment fees associated with the 2029 Term Loan from other assets, net to debt issuance costs upon the $100.0 million draw under the 2029 Term Loan.

*PNC Term Loan Agreement*

On September 25, 2025, the Company entered into a Term Loan Agreement, by and among the Operating Partnership, the Company, the several institutions party thereto, as lenders, and PNC Bank, National Association, as Administrative Agent (the "PNC Term Loan Agreement"), related to a senior unsecured term loan facility consisting of (i) a $200.0 million senior unsecured term loan (the "2031 Term Loan") and (ii) a $250.0 million senior unsecured term loan (the "2032 Term Loan", and together with the 2031 Term Loan, the "PNC Term Loans"). All $200.0 million of the 2031 Term Loan was funded on September 25, 2025. Of the $250.0 million capacity of 2032 Term Loan commitments, $100.0 million in term loans were funded on September 25, 2025, and the remaining $150.0 million will be available as a delayed draw term loan commitment until September 25, 2026. Subject to the terms of the PNC Term Loan Agreement, the PNC Term Loans may be increased to an amount of up to $600.0 million at the Company's request.

The 2031 Term Loan matures on March 25, 2031 and is repayable at the Company's option in whole or in part without premium or penalty. The 2032 Term Loan matures on September 24, 2032 and is repayable at the Company's option in whole or in part, subject to a prepayment premium equal to (i) 2.0% of any amount repaid during the first year of the term, and (ii) 1.0% of any amount repaid during the second year of the term.

The interest rate applicable under the PNC Term Loans is determined by the Company's Investment Grade Rating (as defined in the PNC Term Loan Agreement). Prior to the date the Company obtains an Investment Grade Rating (as defined in the PNC Term Loan Agreement), interest rates are based on the Company's consolidated total leverage ratio and are determined by (A) in the case of the 2031 Term Loan, either (i) SOFR, plus a margin ranging from 1.15% to 1.60%, based on the Company's consolidated total leverage ratio, or (ii) a Base Rate (as defined in the PNC Term Loan Agreement), plus a margin ranging from 0.15% to 0.60%, based on the Company's consolidated total leverage ratio; and (B) in the case of the 2032 Term Loan, either (i) SOFR, plus a margin ranging from 1.50% to 2.20%, based on the Company's consolidated total leverage ratio, or (ii) a Base Rate (as defined in the PNC Term Loan Agreement), plus a margin ranging from 0.50% to 1.20%, based on the Company's consolidated total leverage ratio.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

After the date the Company obtains an Investment Grade Rating, interest rates are based on the Company's Investment Grade Rating, and are determined by (A) in the case of the 2031 Term Loan, either (i) SOFR, plus a margin ranging from 0.80% to 1.60%, based on the Company's Investment Grade Rating and consolidated total leverage ratio, or (ii) a Base Rate, plus a margin ranging from 0.00% to 0.60%, based on the Company's Investment Grade Rating and consolidated total leverage ratio and (B) in the case of the 2032 Term Loan, either (i) SOFR, plus a margin ranging from 1.15% to 2.20%, based on the Company's Investment Grade Rating and consolidated total leverage ratio, or (ii) a Base Rate, plus a margin ranging from 0.15% to 1.20%, based on the Company's Investment Grade Rating and consolidated total leverage ratio.

Additionally, the Company will incur a ticking fee based on the total undrawn amount under the 2032 Term Loan. The ticking fee of 0.20% per annum will accrue from December 25, 2025 until September 25, 2026.

The Company has fully hedged the 2031 Term Loan with an all-in fixed interest rate of 4.59% and has partially hedged $200.0 million of the 2032 Term Loan at an all-in fixed interest rate of 4.92%. The remaining $50.0 million of the 2032 Term Loan is currently unhedged. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings. The interest rate hedges are further described in "Note 7 – Derivative Financial Instruments."

In connection with the entry into the PNC Term Loan Agreement, the Company incurred approximately $3.7 million of debt issuance costs which were allocated between the 2031 Term Loan and 2032 Term Loan in the amounts of $2.2 million and $1.5 million, respectively. Additionally, the Company incurred $2.1 million of loan commitment fees associated with the 2032 Term Loan, which have been capitalized to other assets, net in the condensed consolidated balance sheets. The deferred financing costs and capitalized loan commitment fees are amortized over the term of the loans, and are included in interest expense, net in the Company's condensed consolidated statements of operations and comprehensive loss.

*Truist Credit Agreement*

On July 3, 2023, the Company entered into a Credit Agreement, by and among the Operating Partnership, the Company, the financial institutions party thereto, as lenders, and Truist Bank, as Administrative Agent (the "Truist Credit Agreement"), related to a $250.0 million sustainability-linked senior unsecured term loan (the "2029 Term Loan") which may, subject to the terms of the Truist Credit Agreement, be increased to an amount of up to $400.0 million at the Company's request. On January 15, 2025, the Truist Credit Agreement was amended to remove certain financial covenants and provide for revised, improved pricing when the Company meets certain investment grade rating and leverage targets. On September 25, 2025, the Truist Credit Agreement was further amended to, among other things, remove the SOFR credit spread adjustment from the 2029 Term Loan.

The 2029 Term Loan contains a 12-month delayed draw feature and $150.0 million was drawn on July 3, 2023. Subject to the terms of the Truist Credit Agreement, the Company drew an additional $100.0 million under the 2029 Term Loan on March 1, 2024. The 2029 Term Loan is prepayable at the Company's option in whole or in part without premium or penalty. The 2029 Term Loan matures on July 3, 2026, subject to two one-year extension options and one six-month extension option with a final, extended maturity date of January 3, 2029. The extension options are at the Company's election and are subject to certain conditions.

The interest rate applicable to the 2029 Term Loan is determined by the Company's Investment Grade Rating (as defined in the Truist Credit Agreement). Prior to the date the Company obtains an Investment Grade Rating, interest shall accrue at either (i) SOFR, plus a margin ranging from 1.15% to 1.60% or (ii) Base Rate (as defined in the Truist Credit Agreement), plus a margin ranging from 0.15% to 0.60%, in each case based on the Company's consolidated total leverage ratio. After the date the Company obtains an Investment Grade Rating, interest shall accrue at either (i) SOFR, plus a margin ranging from 0.80% to 1.60% or (ii) Base Rate, plus a margin ranging from 0.00% to 0.60%, in each case based on the Company's Investment Grade Rating.

The 2029 Term Loan also contains sustainability-linked pricing component pursuant to which the Company will receive interest rate reductions up to 0.025% based on its performance against a sustainability performance target focused on the portion of the Company's annualized based rent attributable to tenants with commitments or quantifiable targets for reduced GHG emission in accordance with the standards of the Science Based Targets initiative ("SBTi").

The Company has fully hedged the 2029 Term Loan at an all-in fixed interest rate of 4.89% through January 2029. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings. The interest rate hedges are further described in "Note 7 – Derivative Financial Instruments."

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

In connection with the entry into the 2029 Term Loan, the Company incurred $1.4 million of debt issuance costs. Additionally, the Company incurred $0.9 million of loan commitment fees associated with the 2029 Term Loan, which were capitalized to other assets, net in the condensed consolidated balance sheets and subsequently reclassified to debt issuance costs upon the $100.0 million draw under the 2029 Term Loan. Deferred financing costs are amortized over the term of the loan and are included in interest expense, net in the Company's condensed consolidated statements of operations and comprehensive loss.

*PNC Credit Agreement*

On August 11, 2022, the Company entered into a Credit Agreement, by and among the Operating Partnership, the Company, the several institutions party thereto, as lenders, and PNC Bank, National Association, as Administrative Agent (the "PNC Credit Agreement"), related to sustainability-linked senior unsecured credit facility consisting of (i) a $200.0 million senior unsecured term loan (the "2028 Term Loan") and (ii) a $400.0 million senior unsecured revolving credit facility (the "Revolver").

On January 15, 2025, the Company amended and restated the existing PNC Credit Agreement to provide for: the existing $200.0 million 2028 Term Loan; an upsized $500.0 million Revolver (increased from $400.0 million under the existing PNC Credit Agreement); and a new $175.0 million senior unsecured term loan (the "2030 Term Loan B", and together with the 2028 Term Loan and the Revolver, the "PNC Credit Facility"). On September 25, 2025, the PNC Credit Agreement was further amended to, among other things, remove the SOFR credit spread adjustment from the PNC Credit Facility. The borrowing capacity under the PNC Credit Facility may be increased in an amount of up to $1.4 billion in the aggregate.

The 2028 Term Loan matures on February 11, 2028. The 2030 Term Loan B and the upsized Revolver initially mature on January 15, 2029 and include, at the Company's election, a one-year option to extend the maturity to January 15, 2030. Borrowings under the PNC Credit Facility are repayable at the Company's option in whole or in part without premium or penalty. Borrowings under the Revolver may be repaid and reborrowed from time to time prior to the maturity date.

Prior to the date the Company obtains an Investment Grade Rating (as defined in the PNC Credit Agreement), interest rates are based on the Company's consolidated total leverage ratio and are determined by (A) in the case of the 2028 Term Loan and the 2030 Term Loan B, either (i) SOFR, plus a margin ranging from 1.15% to 1.60%, based on the Company's consolidated total leverage ratio, or (ii) a Base Rate (as defined in the PNC Credit Agreement), plus a margin ranging from 0.15% to 0.60%, based on the Company's consolidated total leverage ratio; and (B) in the case of the Revolver either (i) SOFR, plus a margin ranging from 1.00% to 1.45%, based on the Company's consolidated total leverage ratio, or (ii) a Base Rate (as defined in the PNC Credit Agreement), plus a margin ranging from 0.00% to 0.45%, based on the Company's consolidated total leverage ratio.

After the date the Company obtains an Investment Grade Rating, interest rates are based on the Company's Investment Grade Rating, and are determined by (A) in the case of the 2028 Term Loan and the 2030 Term Loan B, either (i) SOFR, plus a margin ranging from 0.80% to 1.60%, based on the Company's Investment Grade Rating and consolidated total leverage ratio, or (ii) a Base Rate, plus a margin ranging from 0.00% to 0.60%, based on the Company's Investment Grade Rating and consolidated total leverage ratio and (B) in the case of the Revolver either (i) SOFR, plus a margin ranging from 0.725% to 1.40%, based on the Company's Investment Grade Rating and consolidated total leverage ratio, or (ii) a Base Rate, plus a margin ranging from 0.00% to 0.40%, based on the Company's Investment Grade Rating and consolidated total leverage ratio.

Additionally, the Company will incur a facility fee based on the total commitment amount of $500.0 million under the Revolver. Prior to the date the Company obtains an Investment Grade Rating, the applicable facility fee will range from 0.15% to 0.30% based on the Company's consolidated total leverage ratio. After the date the Company obtains an Investment Grade Rating, the applicable facility fee will range from 0.125% to 0.30% based on the Company's Investment Grade Rating.

The PNC Credit Facility also contains a sustainability-linked pricing component pursuant to which the Company will receive interest rate reductions up to 0.025% based on its performance against a sustainability performance target focused on the portion of the Company's annualized base rent attributable to tenants with commitments or quantifiable targets for reduced greenhouse gas emission in accordance with the standards of the SBTi.

The Company has fully hedged the 2028 Term Loan with an all-in fixed interest rate of 3.78%, and the 2030 Term Loan B with an all-in fixed interest rate of 5.02%. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings. The interest rate hedges are further described in "Note 7 – Derivative Financial Instruments."

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

In connection with the entry into the PNC Credit Agreement, the Company incurred approximately $3.8 million of deferred financing costs which were allocated between the Revolver and 2028 Term Loan in the amounts of $2.4 million and $1.3 million, respectively. In connection with the first amendment to the PNC Credit Agreement, the Company incurred approximately $5.1 million of deferred financing costs which were allocated between the Revolver and 2030 Term Loan B in the amounts of $3.7 million and $1.4 million, respectively. Additionally, $0.5 million of unamortized deferred financing costs associated with the Company's previous revolving credit facility were reclassified to the Revolver. Deferred financing costs are amortized over the remaining terms of each respective borrowing and are included in interest expense, net in the Company's condensed consolidated statements of operations and comprehensive loss.

*Wells Fargo Credit Agreement*

In December 2019, the Company entered into a Credit Agreement, by and among the Operating Partnership, the Company, the several institutions party thereto, as lenders, and Wells Fargo Bank, National Association, as Administrative Agent, which was subsequently amended and restated on June 15, 2023 (as amended, the "Wells Fargo Credit Agreement"), governing a $175.0 million senior unsecured term loan that was scheduled to mature on January 15, 2026, subject to a one-year extension option at the Company's election (subject to certain conditions) (the "2027 Term Loan").

On January 15, 2025, the Company amended and restated the Wells Fargo Credit Agreement to extend the maturity date of the 2027 Term Loan to January 15, 2029, subject to a one-year extension option at the Company's election (subject to certain conditions) (as amended, the "2030 Term Loan A"). On September 25, 2025, the Wells Fargo Credit Agreement was further amended to, among other things, remove the SOFR credit spread adjustment from the 2030 Term Loan A. The 2030 Term Loan A is repayable at the Company's option in whole or in part without premium or penalty.

The interest rate applicable to the 2030 Term Loan A is determined by the Company's Investment Grade Rating (as defined in the Wells Fargo Credit Agreement). Prior to the date the Company obtains an Investment Grade Rating, interest shall accrue at either (i) SOFR, plus a margin ranging from 1.15% to 1.60% or (ii) Base Rate (as defined in the Wells Fargo Credit Agreement), plus a margin ranging from 0.15% to 0.60%, in each case based on the Company's consolidated total leverage ratio. After the date the Company obtains an Investment Grade Rating, interest shall accrue at either (i) SOFR, plus a margin ranging from 0.80% to 1.60% or (ii) Base Rate, plus a margin ranging from 0.00% to 0.60%, in each case based on the Company's Investment Grade Rating.

The Company has fully hedged the 2030 Term Loan A with an all-in fixed interest rate of 3.55%. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings. The interest rate hedges are described in "Note 7 – Derivative Financial Instruments."

In connection with the 2030 Term Loan A, the Company incurred $1.1 million of deferred financing costs. Deferred financing costs are amortized over the term of the loan and are included in interest expense, net in the Company's condensed consolidated statements of operations and comprehensive loss.

*Mortgage Note Payable*

As of September 30, 2025, the Company had total gross mortgage indebtedness of $8.1 million, which was collateralized by related real estate and a tenant's lease with an aggregate net book value of $11.8 million. The Company incurred debt issuance costs of less than $0.1 million and recorded a debt discount of $0.6 million, both of which are recorded as a reduction of the principal balance in mortgage note payable, net in the Company's condensed consolidated balance sheets. The mortgage note matures on November 1, 2027, but may be repaid in full beginning August 2027.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

*Debt Maturities*

Payments on the 2028 Term Loan, 2029 Term Loan, 2030 Term Loan A, 2030 Term Loan B, 2031 Term Loan, and 2032 Term Loan are interest-only through maturity. As of September 30, 2025, scheduled debt maturities, including balloon payments, are as follows (in thousands):

---

| | | | |
|:---|:---|:---|:---|
| | **Scheduled Principal Payment** | **Balloon Payment** <sup>(1)</sup> | **Total** |
| Remainder of 2025 | $43 | $— | $43 |
| 2026 | 178 | 250000 | 250178 |
| 2027 | 170 | 7693 | 7863 |
| 2028 |  | 200000 | 200000 |
| 2029 |  | 350000 | 350000 |
| Thereafter |  | 300000 | 300000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $391 | $1107693 | $1108084 |

---

<sup>(1)</sup> Does not assume the exercise of any extension options available to the Company.

*Interest Expense*

The following table is a summary of the components of interest expense related to the Company's borrowings (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Revolving credit facilities <sup>(1)</sup> | $1758 | $1876 | $5324 | $4635 |
| Term loans <sup>(2)</sup> | 9303 | 6528 | 26854 | 18728 |
| Mortgage note payable | 94 | 94 | 280 | 285 |
| Non-cash: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred financing costs | 305 | 186 | 856 | 609 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt discount and debt issuance costs, net | 480 | 401 | 1394 | 1150 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred losses (gains) on interest rate swaps | 720 | (990) | 2138 | (2949) |
| &nbsp;&nbsp;&nbsp;&nbsp;Capitalized interest | (24) | (130) | (112) | (709) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest expense, net | $12636 | $7965 | $36734 | $21749 |

---

<sup>(1)</sup> Includes facility fees of approximately $0.2 million for the three months ended September 30, 2025 and 2024, and facility fees of $0.6 million and $0.5 million for the nine months ended September 30, 2025 and 2024, respectively.

<sup>(2)</sup> Includes the effects of interest rate hedges.

Deferred financing, discount, and debt issuance costs are amortized over the remaining terms of each respective borrowing and are included in interest expense, net in the Company's condensed consolidated statements of operations and comprehensive loss.

During the three months ended September 30, 2025 and 2024, term loans had a weighted average interest rate, exclusive of amortization of deferred financing costs and the effects of interest rate hedges, of 5.36% and 6.62%, respectively. During the nine months ended September 30, 2025 and 2024, term loans had a weighted average interest rate, exclusive of amortization of deferred financing costs and the effects of interest rate hedges, of 5.31% and 6.67%, respectively.

During the three months ended September 30, 2025 and 2024, the Company incurred interest expense on the Revolver with a weighted average interest rate, exclusive of amortization of deferred financing costs and facility fees, of 5.56% and 6.45%, respectively. During the nine months ended September 30, 2025 and 2024, the Company incurred interest expense on the Revolver with a weighted average interest rate, exclusive of amortization of deferred financing costs and facility fees, of 5.47% and 6.49%, respectively.

The Company was in compliance with all of its debt covenants as of September 30, 2025 and expects to be in compliance for the twelve-month period ending December 31, 2025.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**Note 7 – Derivative Financial Instruments**

The Company uses interest rate derivative contracts to manage its exposure to changes in interest rates on its variable rate debt. These derivatives are considered cash flow hedges and are recorded on a gross basis at fair value. Assessments of hedge effectiveness are performed quarterly using either a qualitative or quantitative approach. The Company recognizes the entire change in the fair value in Accumulated Other Comprehensive Income ("AOCI") and the change is reflected as cash flow hedge changes in fair value in the supplemental disclosures of non-cash investing and financing activities in the condensed consolidated statements of cash flows.

Amounts will subsequently be reclassified to earnings when the hedged item affects earnings. The Company does not enter into derivative contracts for speculative or trading purposes and does not have derivative netting arrangements.

The Company is exposed to credit risk in the event of non-performance by its derivative counterparties. The Company evaluates counterparty credit risk through monitoring the creditworthiness of counterparties, which includes review of debt ratings and financial performance. To mitigate credit risk, the Company enters into agreements with counterparties it considers credit-worthy, such as large financial institutions with favorable credit ratings.

The following table summarizes the terms and fair values of the Company's interest rate derivative contracts that were designated as cash flow hedges of interest rate risk as of September 30, 2025 and December 31, 2024 (dollars in thousands):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Number of Instruments** | **Number of Instruments** | | | **Aggregate Notional Value** | **Aggregate Notional Value** | **Fair Value of Asset (Liability)**<sup>(2)</sup> | **Fair Value of Asset (Liability)**<sup>(2)</sup> |
|<br>**Associated Debt Instrument** | **September 30, 2025** | **December 31, 2024** |<br>**Hedge Fixed Rate**<sup>(1)</sup> |<br>**Maturity Dates** | **September 30, 2025** | **December 31, 2024** | **September 30, 2025** | **December 31, 2024** |
| 2028 Term Loan | 3 | 3 | 2.63% | February 11, 2028 | $200000 | $200000 | $3126 | $7971 |
| 2029 Term Loan | 4 | 4 | 3.74% | January 3, 2029 | 250000 | 250000 | (3416) | 2165 |
| 2030 Term Loan A | 4 | 4 | 2.40% | January 23, 2027 | 175000 | 175000 | 2471 | 5629 |
| 2030 Term Loan B | 7 | 7 | 3.87% | January 2, 2030 | 175000 | 175000 | (3900) | 661 |
| 2031 Term Loan | 8 |  | 3.44% | March 1, 2031 | 200000 |  | (826) |  |
| 2032 Term Loan | 8 |  | 3.42% | September 1, 2032 | 200000 |  | (79) |  |
| &nbsp;&nbsp;Total | 34 | 18 |  |  | $1200000 | $800000 | $(2624) | $16426 |

---

<sup>(1)</sup> Represents the weighted-average hedge fixed rate of the derivative contracts for each associated debt instrument and excludes the associated applicable margin as described in "Note 6 **–** Debt."

<sup>(2)</sup> Derivative contracts in asset positions are included within other assets, net and derivative contracts in liability positions are included within accounts payable, accrued expenses, and other liabilities in the condensed consolidated balance sheets as of September 30, 2025 and December 31, 2024.

The following table presents the effect of the Company's interest rate swaps in the condensed consolidated statements of operations and comprehensive loss for the three and nine months ended September 30, 2025 and 2024 (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)** | **Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)** | **Location of Gain (Loss) Reclassified from Accumulated OCI <br>into Income (Effective Portion)** | **Amount of Gain (Loss) Reclassified from Accumulated OCI <br>into Income (Effective Portion)** | **Amount of Gain (Loss) Reclassified from Accumulated OCI <br>into Income (Effective Portion)** |
| | **Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)** | **Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)** | **Location of Gain (Loss) Reclassified from Accumulated OCI <br>into Income (Effective Portion)** | **Amount of Gain (Loss) Reclassified from Accumulated OCI <br>into Income (Effective Portion)** | **Amount of Gain (Loss) Reclassified from Accumulated OCI <br>into Income (Effective Portion)** |
| | **Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)** | **Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)** | **Location of Gain (Loss) Reclassified from Accumulated OCI <br>into Income (Effective Portion)** | **Amount of Gain (Loss) Reclassified from Accumulated OCI <br>into Income (Effective Portion)** | **Amount of Gain (Loss) Reclassified from Accumulated OCI <br>into Income (Effective Portion)** |
| **Derivatives in Cash Flow Hedging Relationships** | **2025** | **2024** |  | **2025** | **2024** |
| **For the Three Months Ended September 30** |  |  |  |  |  |
| Interest Rate Products | $201 | $(15724) | Interest expense, net | $1605 | $4890 |
| **For the Nine Months Ended September 30** |  |  |  |  |  |
| Interest Rate Products | $(12251) | $2933 | Interest expense, net | $4660 | $14389 |

---

The Company did not exclude any amounts from the assessment of hedge effectiveness for the three and nine months ended September 30, 2025 and 2024. During the next twelve months, the Company estimates that an additional $0.7 million will be reclassified as a decrease to interest expense.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**Note 8 – Fair Value Measurements**

GAAP establishes a hierarchy of valuation techniques based on the observability of inputs used in measuring financial instruments at fair value. GAAP establishes market-based or observable inputs as the preferred source of values, followed by valuation models using management assumptions in the absence of market inputs.

The determination of where an asset or liability falls in the hierarchy requires significant judgment and considers factors specific to the asset or liability. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.

*Financial Assets and Liabilities*

Companies are required to disclose the estimated fair values of all financial instruments, even if those instruments are not carried at fair value. The fair values of financial instruments are based on estimates that reflect market conditions and perceived risks as of September 30, 2025 and December 31, 2024. These estimates require management's judgment and may not be indicative of the future fair values of the assets and liabilities.

The carrying values of the Company's cash, cash equivalents, and restricted cash (including money market accounts), other assets, and accounts payable, accrued expenses, and other liabilities approximate their fair values due to the short-term nature of these instruments. Additionally, the Company believes that the following financial instruments have carrying values that approximate their fair values as of September 30, 2025:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Borrowings under the Company's Revolver (as defined in "Note 6 – Debt") approximate fair value based on their nature, terms, and variable interest rates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Carrying values of the Company's mortgage loans receivable approximate fair value based on a number of factors, including either their short-term nature, the availability of market quotes for comparable instruments, and a discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates, and credit spreads.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Carrying value of the Company's mortgage note payable approximates fair value based on a discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates, and credit spreads.

The table below presents the carrying values and estimated fair values of certain financial assets and liabilities as of September 30, 2025 and December 31, 2024, aggregated by their level in the fair value hierarchy within which those measurements fall (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | | **Fair Value Hierarchy Level** | **Fair Value Hierarchy Level** | **Fair Value Hierarchy Level** |
| **Description** |<br>**Carrying Value** |<br>**Fair Value** | **Level 1** | **Level 2** | **Level 3** |
| **September 30, 2025** | | | | | |
| &nbsp;&nbsp;*Assets* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivative assets | $5597 | $5597 | $— | $5597 | $— |
| &nbsp;&nbsp;*Liabilities* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivative liabilities | $8221 | $8221 | $— | $8221 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Term loans <sup>(1)</sup> | $1092846 | $1104202 | $— | $— | $1104202 |
| **December 31, 2024** |  |  |  |  |  |
| &nbsp;&nbsp;*Assets* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivative assets | $16426 | $16426 | $— | $16426 | $— |
| &nbsp;&nbsp;*Liabilities* |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Term loans <sup>(1)</sup> | $622608 | $626629 | $— | $— | $626629 |

---

<sup>(1)</sup> Recorded at carrying value in the condensed consolidated balance sheets which represents amortized cost, net of unamortized debt issuance and discount costs.

The estimated fair values of the Company's term loans (each as defined in "Note 6 – Debt") are derived based primarily on unobservable market inputs such as interest rates and discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates, and credit spreads (Level 3 inputs).

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

The Company's derivative assets and liabilities are measured at fair value on a recurring basis. The estimated fair values are determined using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves.

To comply with the provisions of ASC 820, Fair Value Measurement, the Company incorporates credit valuation adjustments to appropriately reflect both its own nonperformance risk and the respective counterparty's nonperformance risk in the fair value measurements. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts, and guarantees.

Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by itself and its counterparties. However, as of September 30, 2025, the Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of its derivatives. As a result, the Company has determined that its derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy.

*Nonfinancial Assets and Liabilities*

Certain nonfinancial assets and liabilities are measured at fair value on a non-recurring basis and are subject to fair value adjustments only under certain circumstances, such as when an impairment write-down occurs. Depending on impairment triggering events, impairments are typically recorded for properties sold, in the process of being sold, vacant, in bankruptcy, or experiencing difficulties with collection of rent.

The following table summarizes the provisions for impairment on real estate investments during the periods indicated below (dollars in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Carrying value prior to impairment | $37870 | $48237 | $80992 | $101196 |
| Less: total provisions for impairment | (4134) | (9838) | (12173) | (17336) |
| Carrying value after impairment | $33736 | $38399 | $68819 | $83860 |
| Number of properties: <sup>(1)</sup> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified as held for sale | 5 | 12 | 11 | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;Disposed within the period | 7 | 3 | 21 | 14 |
| &nbsp;&nbsp;&nbsp;&nbsp;Classified as held for investment | 1 | 3 | 2 | 9 |

---

<sup>(1)</sup> Includes the number of properties that were either (i) impaired during the respective period and remained as held for sale as of period-end, (ii) impaired and disposed during the respective period, or (iii) impaired during the respective period and remained as held for investment at period-end.

The valuation of impaired assets is determined using data such as operating income, estimated capitalization rates or multiples, leasing prospects, local market information, analysis of recent comparable sales transactions, discount rates, and purchase offers from third parties, all of which represent Level 3 inputs. The Company may consider a single valuation technique or multiple valuation techniques, as appropriate, when estimating the fair value of such real estate. Estimating future cash flows is inherently subjective, and actual results may differ materially from these estimates. During the three and nine months ended September 30, 2025, the Company accounted for held for investment assets at fair value using a cash flow model (Level 3 inputs) with capitalization rates ranging from 6.2% to 7.5%, which the Company believes is reasonable based on current market rates.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**Note 9 – Supplemental Detail for Certain Components of the Condensed Consolidated Balance Sheets**

Other assets, net consists of the following (in thousands):

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Accounts receivable, net | $8763 | $9809 |
| Deferred rent receivable | 15331 | 11790 |
| Prepaid assets | 4286 | 2143 |
| Earnest money deposits | 993 | 517 |
| Fair value of interest rate swaps | 5597 | 16426 |
| Deferred offering costs | 2400 | 1641 |
| Deferred financing costs, net | 6032 | 1200 |
| Right-of-use asset | 3187 | 3484 |
| Leasehold improvements and other corporate assets, net | 1240 | 1425 |
| Interest receivable | 3737 | 3034 |
| Other assets, net | 5392 | 6758 |
|  | $56958 | $58227 |

---

Accounts payable, accrued expenses, and other liabilities consist of the following (in thousands):

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Accrued expenses | $8585 | $4961 |
| Accrued bonus | 2118 | 1271 |
| Prepaid rent | 4757 | 5655 |
| Operating lease liability | 4281 | 4646 |
| Accrued interest | 3928 | 3476 |
| Deferred rent | 4985 | 4738 |
| Accounts payable | 554 | 3053 |
| Fair value of interest rate swaps | 8221 |  |
| Other liabilities | 4528 | 1864 |
|  | $41957 | $29664 |

---

**Note 10 – Shareholders' Equity** 

*ATM Programs*

On October 25, 2023, the Company entered into a $300.0 million at-the-market equity program (the "2023 ATM Program") through which, from time to time, it may sell shares of its common stock in registered transactions.

During 2024, the Company entered into forward sale agreements with respect to an aggregate 1,743,100 shares of its common stock under the 2023 ATM Program at a weighted-average price of $17.67 per share. As of September 30, 2025, 1,743,100 shares remain unsettled under the forward sale agreements. The Company may physically settle the forward sale agreements (by the delivery of shares of common stock) and receive proceeds from the sale of those shares on one or more forward settlement dates, which shall occur no later than December 31, 2026.

On August 12, 2024, the Company entered into a $300.0 million at-the-market equity program (the "2024 ATM Program") through which, from time to time, it may sell shares of its common stock in registered transactions. Effective August 12, 2024, in connection with the establishment of the new at-the-market offering program, the 2023 ATM Program was terminated. As a result of the termination, the Company will not offer or sell any additional shares of common stock under the 2023 ATM Program. As context requires, the 2024 ATM Program, and the 2023 ATM Program are referred to herein as the "ATM Programs."

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

During 2024, the Company entered into forward sale agreements with respect to an aggregate 152,547 shares of its common stock under the 2024 ATM Program at a weighted-average price of $17.13 per share. As of September 30, 2025, 152,547 shares remain unsettled under the forward sale agreements. The Company may physically settle the forward sale agreements (by the delivery of shares of common stock) and receive proceeds from the sale of those shares on one or more forward settlement dates, which shall occur no later than December 31, 2025.

During 2025, the Company entered into forward sale agreements with respect to an aggregate 3,342,894 shares of its common stock under the 2024 ATM Program at a weighted-average price of $16.95 per share. As of September 30, 2025, 2,237,595 shares remain unsettled under the forward sale agreements. The Company may physically settle the forward sale agreements (by the delivery of shares of common stock) and receive proceeds from the sale of those shares on one or more forward settlement dates, which shall occur no later than the stated maturity dates of April 30, 2026, June 11, 2026, September 8, 2026, and September 9, 2026.

The following table presents information about the ATM Programs (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Date** <br>**Established** | **Date Terminated** | **Maximum Sales Authorization** | **Gross Settlements through September 30, 2025** <sup>(1)</sup> | **Gross Proceeds Available as of September 30, 2025** <sup>(2)</sup> |
| | **Date** <br>**Established** | **Date Terminated** | **Maximum Sales Authorization** | **Gross Settlements through September 30, 2025** <sup>(1)</sup> | **Gross Proceeds Available as of September 30, 2025** <sup>(2)</sup> |
|<br>**Program Name** | **Date** <br>**Established** | **Date Terminated** | **Maximum Sales Authorization** | **Gross Settlements through September 30, 2025** <sup>(1)</sup> | **Gross Proceeds Available as of September 30, 2025** <sup>(2)</sup> |
| 2023 ATM Program <sup>(3)</sup> | October 2023 | August 2024 | $300000 | $77323 | $30806 |
| 2024 ATM Program <sup>(4)</sup> | August 2024 |  | $300000 | $28694 | $271306 |

---

<sup>(1)</sup> Represents shares of common stock issued by the Company under the ATM Programs, including settlements of forward sale agreements.

<sup>(2)</sup> Represents gross proceeds available for future issuances of shares of common stock under the ATM Programs, inclusive of unsettled shares under forward sale agreements.

<sup>(3)</sup> As of September 30, 2025, 1,743,100 shares remain unsettled under the forward sale agreements at a weighted-average available net settlement price of $17.33.

<sup>(4)</sup> As of September 30, 2025, 2,390,142 shares remain unsettled under the forward sale agreements at a weighted-average available net settlement price of $17.06.

The following table details information related to activity under the ATM Programs for the three and nine months ended September 30, 2025 and 2024 (in thousands, except share and per share data). There was no activity during the three months ended September 30, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** <sup>(1)</sup> | **2025** <sup>(2)</sup> | **2024** <sup>(3)</sup> |
| Shares of common stock issued |  | 1983711 | 1757815 | 5983711 |
| Weighted average price per share | $— | $16.50 | $16.32 | $16.50 |
| Gross proceeds | $— | $32731 | $28694 | $98731 |
| Sales commissions and offering costs | $— | $394 | $342 | $1070 |
| Net proceeds <sup>(4)</sup> | $— | $32337 | $28352 | $97661 |

---

<sup>(1)</sup> Includes 1,983,711 shares of common stock that were physically settled at a weighted-average price of $16.50 per share under forward sale agreements.

<sup>(2)</sup> Includes 1,105,299 shares of common stock that were physically settled at a weighted-average price of $16.37 per share under forward sale agreements.

<sup>(3)</sup> Includes 5,983,711 shares of common stock that were physically settled at a weighted-average price of $16.50 per share under forward sale agreements.

<sup>(4)</sup> The net proceeds were contributed to the Operating Partnership in exchange for an equivalent number of Class A OP Units.

*July 2025 Follow-On Offering*

In July 2025, the Company completed a registered public offering of 12,420,000 shares of its common stock at a public offering price of $17.70 per share, including the full exercise of the underwriter's option to purchase additional shares. In connection with the offering, the Company entered into forward sale agreements for 12,420,000 shares of its common stock. The Company did not initially receive any proceeds from the sale of shares of common stock by the forward purchasers. The Company expects to physically settle the forward sale agreements (by delivery of shares of common stock) and receive proceeds from the sale of those shares upon one or more forward settlement dates, which shall occur no later than July 28, 2026. As of September 30, 2025, 12,420,000 shares remain unsettled under the July 2025 forward sale agreements.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

*January 2024 Follow-On Offering*

In January 2024, the Company completed a registered public offering of 11,040,000 shares of its common stock at a public offering price of $18.00 per share. In connection with the offering, the Company entered into forward sale agreements for 11,040,000 shares of its common stock. The Company did not initially receive any proceeds from the sale of shares of common stock by the forward purchasers. On September 26, 2024, the Company partially physically settled 2,200,000 shares of common stock at a price of $17.22 per share in accordance with the forward sale agreements. The Company received net proceeds from the settlement of $37.8 million, net of underwriting discounts and offering costs of $1.8 million. The Company contributed the net proceeds to the Operating Partnership in exchange for 2,200,000 Class A OP Units.

The Company expects to physically settle the forward sale agreements (by delivery of shares of common stock) and receive proceeds from the sale of those shares upon one or more forward settlement dates, which shall occur no later than December 31, 2026. As of September 30, 2025, 8,840,000 shares remain unsettled under the January 2024 forward sale agreements.

*Surrendered Shares on Vested Stock Unit Awards*

During the nine months ended September 30, 2025 and 2024, portions of restricted stock unit awards ("RSUs") granted to certain of the Company's officers, directors, and employees vested. The vesting of these awards, granted pursuant to the NETSTREIT Corp. Amended and Restated 2019 Omnibus Incentive Plan (the "Omnibus Incentive Plan"), resulted in federal and state income tax liabilities for the recipients. During the nine months ended September 30, 2025 and 2024, as permitted by the terms of the Omnibus Incentive Plan and the award grants, certain executive officers and employees elected to surrender approximately 50 thousand and 77 thousand RSUs valued at approximately $0.7 million and $1.3 million, respectively, solely to pay the associated statutory withholding tax. The surrendered RSUs are included in the row entitled "repurchase of common stock for tax withholding obligations" in the condensed consolidated statements of cash flows and condensed consolidated statements of changes in equity.

*Dividends*

During the nine months ended September 30, 2025, the Company declared and paid the following common stock dividends (in thousands, except per share data):

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| **Declaration Date** | **Dividend Per Share** | **Record Date** | **Total Amount** | **Payment Date** |
| February 21, 2025 | $0.210 | March 14, 2025 | $17157 | March 31, 2025 |
| April 25, 2025 | 0.210 | June 2, 2025 | 17159 | June 16, 2025 |
| July 21, 2025 | 0.215 | September 2, 2025 | 17947 | September 15, 2025 |
|  | $0.635 |  | $52263 |  |

---

During the nine months ended September 30, 2024, the Company declared and paid the following common stock dividends (in thousands, except per share data):

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** | **Nine Months Ended September 30, 2024** |
| **Declaration Date** | **Dividend Per Share** | **Record Date** | **Total Amount** | **Payment Date** |
| February 13, 2024 | $0.205 | March 15, 2024 | $15031 | March 28, 2024 |
| April 23, 2024 | 0.205 | June 3, 2024 | 15042 | June 14, 2024 |
| July 23, 2024 | 0.210 | September 3, 2024 | 16251 | September 13, 2024 |
|  | $0.620 |  | $46324 |  |

---

The holders of OP Units are entitled to receive an equal distribution for each OP Unit held as of each record date. Accordingly, during both the nine months ended September 30, 2025 and 2024, the Operating Partnership paid distributions of $0.3 million to holders of OP Units.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

*Noncontrolling Interests*

Noncontrolling interests represent noncontrolling holders of OP Units in the Operating Partnership. OP Units are convertible into common stock as the OP Units may be redeemed for cash or, at the Company's election, exchanged for shares of the Company's common stock on a one-for-one basis. As of September 30, 2025 and December 31, 2024, noncontrolling interests represented 0.5% of OP Units. During the three months ended September 30, 2025 and 2024, OP Unit holders redeemed 5,694 and 12,102 OP Units, respectively, into shares of common stock on a one-for-one basis. During the nine months ended September 30, 2025 and 2024, OP Unit holders redeemed 5,694 and 54,342 OP Units, respectively, into shares of common stock on a one-for-one basis.

**Note 11 – Stock-Based Compensation**

Under the Omnibus Incentive Plan, 4,294,976 shares of common stock are reserved for issuance. The Omnibus Incentive Plan provides for the grant of stock options, stock appreciation rights, restricted shares, RSUs, long-term incentive plan units, dividend equivalent rights, and other share-based, share-related, or cash-based awards, including performance-based awards, to employees, directors, and consultants, with each grant evidenced by an award agreement providing the terms of the award. The Omnibus Incentive Plan is administered by the Compensation Committee of the Board of Directors.

As of September 30, 2025, the only stock-based compensation granted by the Company were RSUs. The total amount of stock-based compensation costs recognized in general and administrative expense in the accompanying condensed consolidated statements of operations and comprehensive loss was $1.5 million and $1.4 million for the three months ended September 30, 2025 and 2024, respectively. Stock-based compensation expense was $4.4 million and $4.7 million for the nine months ended September 30, 2025 and 2024, respectively. All awards of unvested restricted stock units are expected to fully vest over the next one to five years.

*Service-Based RSUs*

Pursuant to the Omnibus Incentive Plan, the Company has made service-based RSU grants to certain employees and non-employee directors. The vesting terms of these grants are specific to the individual grant and vest in equal annual installments over the next one to five years.

The following table summarizes service-based RSU activity for the period ended September 30, 2025:

---

| | | |
|:---|:---|:---|
| | **Shares** | **Weighted Average Grant Date Fair Value per Share** |
| Unvested RSU grants outstanding as of December 31, 2024 | 326987 | $18.25 |
| Granted during the period | 279345 | 14.55 |
| Forfeited during the period | (2963) | 17.01 |
| Vested during the period | (163112) | 18.70 |
| Unvested RSU grants outstanding as of September 30, 2025 | 440257 | $15.74 |

---

For the three months ended September 30, 2025 and 2024, the Company recognized $0.9 million and $0.8 million, respectively, in stock-based compensation expense associated with service-based RSUs. For the nine months ended September 30, 2025 and 2024, the Company recognized $2.6 million and $2.6 million, respectively, in stock-based compensation expense associated with service-based RSUs. As of September 30, 2025 and December 31, 2024, the remaining unamortized stock-based compensation expense totaled $4.5 million and $3.3 million, respectively, and as of September 30, 2025, these awards are expected to be recognized over a remaining weighted average period of 2.0 years. Stock-based compensation expense is recognized on a straight-line basis over the total requisite service period for the entire award.

The grant date fair value of service-based unvested RSUs is calculated as the per share price determined in the initial public offering for awards granted in 2020, and as the per share price of the Company's stock on the date of grant for those granted in years subsequent to 2020.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

*Performance-Based RSUs (total shareholder return)*

Pursuant to the Omnibus Incentive Plan, the Company has made performance-based RSU grants to certain employees. These grants are subject to the participant's continued service over a three year period with 40% of the award based on the Company's total shareholder return ("TSR") as compared to the TSR of identified peer companies and 60% of the award based on total absolute TSR over the cumulative three year period. The performance period of these grants runs through February 28, 2026, December 31, 2026, and December 31, 2027. Grant date fair value of the performance-based share awards was calculated using the Monte Carlo simulation model, which incorporated stock price volatility of the Company and each of the Company's peers and other variables over the performance period. Significant inputs for the current period calculation were expected volatility of the Company of 24.4% and expected volatility of the Company's peers, ranging from 19.5% to 98.2%, with an average volatility of 29.9% and a risk-free interest rate of 4.00%. The fair value per share on the grant date specific to the target TSR relative to the Company's peers was $15.86 and the target absolute TSR was $14.28 for a weighted average grant date fair value of $14.91 per share. Stock-based compensation expense associated with unvested performance-based share awards is recognized on a straight-line basis over the minimum required service period of three years.

The following table summarizes performance-based RSU activity for the period ended September 30, 2025:

---

| | | |
|:---|:---|:---|
| | **Shares** | **Weighted Average Grant Date Fair Value per Share** |
| Unvested RSU grants outstanding as of December 31, 2024 | 290442 | $18.75 |
| Granted during the period | 170213 | 14.91 |
| Forfeited during the period | (68525) | 22.38 |
| Unvested RSU grants outstanding as of September 30, 2025 | 392130 | $16.45 |

---

For the three months ended September 30, 2025 and 2024, the Company recognized $0.6 million and $0.5 million, respectively, in stock-based compensation expense associated with performance-based RSUs. For both the nine months ended September 30, 2025 and 2024, the Company recognized $1.6 million in stock-based compensation expense associated with performance-based RSUs. As of September 30, 2025 and December 31, 2024, the remaining unamortized stock-based compensation expense totaled $3.3 million and $2.4 million, respectively, and as of September 30, 2025, these awards are expected to be recognized over a remaining weighted average period of 1.9 years.

*Alignment of Interest Program*

During March 2021, the Company adopted the Alignment of Interest Program (the "Program"), which allows employees to elect to receive a portion of their annual bonus in RSUs in the first quarter of the following year, that vest from one to four years based on the terms of the grant agreement. Stock-based compensation expense is recognized on a straight-line basis over the total requisite service period for the entire award, which begins in the period the bonus relates to. The Program is deemed to be a liability-classified award (accounted for as an equity-classified award as the service date precedes the grant date and the award would otherwise be classified as equity on grant date), which will be fair-valued and accrued over the applicable service period. The total estimated fair value of the elections made for 2025 under the Program was approximately $1.1 million as of September 30, 2025. The award will be remeasured to fair value each reporting period until the unvested RSUs are granted. For the three and nine months ended September 30, 2025, the Company recognized approximately $0.1 million and $0.2 million, respectively, of stock-based compensation expense associated with these awards. Previous awards under the Program that have been granted are included within service-based RSUs above.

**Note 12 – Earnings Per Share**

Net income (loss) per common share has been computed pursuant to the guidance in the ASC Topic 260, Earnings per Share. Basic earnings per share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per share is similarly calculated except that the denominator is increased by using the treasury stock method to determine the potential dilutive effect of the Company's outstanding unvested RSUs and unsettled shares under open forward equity contracts and using the if-converted method to determine the potential dilutive effect of the OP Units. The Company has noncontrolling interests in the form of OP Units which are convertible into common stock and represent potentially dilutive securities, as the OP Units may be redeemed for cash or, at the Company's election, exchanged for shares of the Company's common stock on a one-for-one basis.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

The following table is a reconciliation of the numerator and denominator used in the computation of basic and diluted net income (loss) per common share for the three and nine months ended September 30, 2025 and 2024.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| (In thousands, except share and per share data) | **2025** | **2024** | **2025** | **2024** |
| **Numerator:** |  |  |  |  |
| Net income (loss) | $621 | $(5322) | $5610 | $(6576) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net (income) loss attributable to noncontrolling interest | (3) | 27 | (29) | 35 |
| Net income (loss) attributable to common shares, basic | 618 | (5295) | 5581 | (6541) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to noncontrolling interest | 3 | (27) | 29 | (35) |
| Net income (loss) attributable to common shares, diluted | $621 | $(5322) | $5610 | $(6576) |
| **Denominator:** |  |  |  |  |
| Weighted average common shares outstanding, basic | 83472089 | 77610680 | 82344168 | 74822286 |
| Effect of dilutive shares for diluted net income per common share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OP Units | 421954 |  | 423944 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unvested RSUs | 420132 |  | 218847 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unsettled shares under open forward equity contracts | 1327773 |  | 442591 |  |
| Weighted average common shares outstanding, diluted | 85641948 | 77610680 | 83429550 | 74822286 |
| Net income (loss) available to common stockholders per common share, basic | $0.01 | $(0.07) | $0.07 | $(0.09) |
| Net income (loss) available to common stockholders per common share, diluted | $0.01 | $(0.07) | $0.07 | $(0.09) |

---

For the three months ended September 30, 2024, diluted net loss per common share does not assume the conversion of 433,942 OP Units, 115,703 unvested RSUs, or 10,219 unsettled shares under open forward equity contracts, as such conversion would be antidilutive.

For the nine months ended September 30, 2024, diluted net loss per common share does not assume the conversion of 450,952 OP Units, 117,761 unvested RSUs, or 311,475 unsettled shares under open forward equity contracts, as such conversion would be antidilutive.

As of September 30, 2025 and December 31, 2024, there were 419,262 and 424,956 OP Units outstanding, respectively.

**Note 13 – Commitments and Contingencies**

*Litigation and Regulatory Matters*

In the ordinary course of business, the Company may, from time to time, be subject to litigation, claims, and regulatory matters. There are none currently outstanding that the Company believes could have, individually or in the aggregate, a material adverse effect on its business, financial condition or results of operations, liquidity, or cash flows.

*Environmental Matters*

The Company is subject to environmental regulations related to the ownership of real estate. The cost of complying with the environmental regulations was not material to the Company's results of operations for any of the periods presented. The Company is not aware of any environmental condition on any of its properties that is likely to have a material adverse effect on the condensed consolidated financial statements when the fair value of such liability can be reasonably estimated and is required to be recognized.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

*Commitments*

In the normal course of business, the Company enters into various types of commitments to purchase real estate properties, fund development projects, or extend funds under mortgage loans receivable. These commitments are generally subject to the Company's customary due diligence process and, accordingly, a number of specific conditions must be met before the Company is obligated to purchase or extend funding. As of September 30, 2025, the Company had tenant improvement allowance commitments totaling approximately $6.3 million, commitments to fund property developments totaling $6.3 million, and commitments to extend funds under mortgage loans receivable of $11.4 million, all of which are expected to occur by the end of 2026.

In August 2021, the Company entered into a lease agreement on a new corporate office space, which is classified as an operating lease. The Company began operating out of the new office in February 2022. The lease has a remaining noncancellable term of 6.8 years that expires on July 31, 2032 and is renewable at the Company's option for two additional periods of five years. Annual rent expense, excluding operating expenses, is approximately $0.5 million during the initial term.

As of September 30, 2025, the Company did not have any other material commitments for re-leasing costs, recurring capital expenditures, non-recurring building improvements, or similar types of costs.

**Note 14 – Subsequent Events**

The Company has evaluated all events that occurred subsequent to September 30, 2025 through the date on which these condensed consolidated financial statements were issued to determine whether any of these events required disclosure in the financial statements.

*Common Stock Dividend*

On October 24, 2025, the Company's Board of Directors declared a cash dividend of $0.215 per share for the fourth quarter of 2025. The dividend will be paid on December 15, 2025 to stockholders of record on December 1, 2025.

*Forward Equity Sales*

In October 2025, the Company entered into forward sale agreements with respect to an aggregate 1,556,592 shares of its common stock under the 2024 ATM Program at a weighted-average price of $18.26 per share. The Company may physically settle the forward sale agreements (by the delivery of shares of common stock) and receive proceeds from the sale of those shares on one or more forward settlement dates, which shall occur no later than October 1, 2026.

*ATM Settlements*

In October 2025, the Company issued 82,500 shares of common stock under the 2024 ATM Program at a price of $18.10 per share for net proceeds of approximately $1.5 million.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**Item 2. *Management's Discussion and Analysis of Financial Condition and Results of Operations*** 

*Special Note Regarding Forward-Looking Statements*

*This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements concerning our business and growth strategies, investment, financing and leasing activities and trends in our business, including trends in the market for single-tenant, retail commercial real estate. Words such as "expects," "anticipates," "intends," "plans," "likely," "will," "believes," "seeks," "estimates," and variations of such words and similar expressions are intended to identify such forward-looking statements. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from the results of operations or plans expressed or implied by such forward-looking statements. Although we believe that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore such statements included in this Quarterly Report on Form 10-Q may not prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by us or any other person that the results or conditions described in such statements or our objectives and plans will be achieved. For a further discussion of these and other factors that could impact future results, performance or transactions, see the information under the heading "Risk Factors" Part I, Item 1A. in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission (the "SEC") on February 24, 2025, and other reports filed with the Securities and Exchange Commission from time to time.*

*Forward-looking statements and such risks, uncertainties and other factors speak only as of the date of this Quarterly Report on Form 10-Q. New risks and uncertainties may arise over time and it is not possible for us to predict those events or how they may affect us. We expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein, to reflect any change in our expectations with regard thereto, or any other change in events, conditions or circumstances on which any such statement is based, except to the extent otherwise required by law.*

**Business Overview**

We are an internally managed real estate company that acquires, owns, and manages a diversified portfolio of single-tenant commercial retail properties, subject to long-term net leases with high-credit-quality tenants across the United States. We also invest in property developments and mortgage loans secured by real estate. As of September 30, 2025, we owned or had investments in 723 properties diversified by tenant, industry, and geography, comprising 114 different tenants across 28 retail sectors in 45 states. This includes two property developments where rent has not yet commenced. We focus on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants, all of which we refer to as defensive retail industries. As of September 30, 2025, our investments generated ABR<sup>1</sup> of $183.2 million. Approximately 47% of our ABR is from investment grade<sup>2</sup> credit rated tenants and an additional 15% of our ABR is derived from tenants with an investment grade profile<sup>3</sup>. Our portfolio was 99.9% occupied and, excluding mortgage loans receivable, had a weighted average remaining lease term ("WALT") of 9.9 years.

<sup>1</sup> Annualized base rent ("ABR") is annualized base rent for all leases that commenced and annualized cash interest for all executed mortgage loans as of September 30, 2025.

<sup>2</sup> We define "investment grade" tenants as tenants, or tenants that are subsidiaries of a parent entity, with a credit rating of BBB- (S&P/Fitch), Baa3 (Moody's), or NAIC2 (National Association of Insurance Commissioners) or higher.

<sup>3</sup> We define "investment grade profile" tenants as tenants with metrics of more than $1.0 billion in annual sales and a debt to adjusted EBITDA ratio of less than 2.0x but do not carry a published rating from S&P, Moody's, or NAIC.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

*July 2025 Follow-On Offering*

In July 2025, we completed a registered public offering of 12,420,000 shares of our common stock at a public offering price of $17.70 per share, including the full exercise of the underwriter's option to purchase additional shares. In connection with the offering, we entered into forward sale agreements for 12,420,000 shares of our common stock. We did not initially receive any proceeds from the sale of shares of common stock by the forward purchasers. We expect to physically settle the forward sale agreements (by delivery of shares of common stock) and receive proceeds from the sale of those shares upon one or more forward settlement dates, which shall occur no later than July 28, 2026. As of September 30, 2025, 12,420,000 shares remain unsettled under the July 2025 forward sale agreements.

*September 2025 Debt Transactions*

On September 25, 2025, we entered into a Term Loan Agreement (the "PNC Term Loan Agreement") which provides for: a $200.0 million senior unsecured term loan (the "2031 Term Loan"), all of which was funded on the closing date, and a $250.0 million senior unsecured term loan (the "2032 Term Loan"), of which $100.0 million was funded on the closing date and the remaining $150.0 million will be available as a delayed draw term loan commitment until September 25, 2026. The 2031 Term Loan matures on March 25, 2031 and the 2032 Term Loan matures on September 24, 2032. We have fully hedged the 2031 Term Loan at an all-in fixed interest rate of 4.59% through March 2031. We have partially hedged $200.0 million of the 2032 Term Loan at an all-in fixed interest rate of 4.92% through September 2032, with the remaining $50.0 million of the 2032 Term Loan currently unhedged. Further, we amended our existing credit agreements agented by PNC Bank, National Association (the "PNC Credit Agreement"), Wells Fargo Bank, National Association (the "Wells Fargo Credit Agreement") and Truist Bank (the "Truist Credit Agreement"), implementing certain conforming changes including, without limitation, removing the SOFR credit spread adjustments in those agreements.

*ATM Program*

During 2025, we entered into forward sale agreements with respect to an aggregate 3,342,894 shares of common stock under our existing ATM program at a weighted-average price of $16.95 per share. As of September 30, 2025, 2,237,595 shares remain unsettled under the forward sale agreements. We may physically settle the forward sale agreements (by the delivery of shares of common stock) and receive proceeds from the sale of those shares on one or more forward settlement dates, which shall occur no later than the stated maturity dates of April 30, 2026, June 11, 2026, September 8, 2026, and September 9, 2026.

The following table details information related to activity under the ATM program for the nine months ended September 30, 2025 (in thousands, except share and per share data). There was no activity during the three months ended September 30, 2025.

---

| | |
|:---|:---|
| | **Nine Months Ended September 30, 2025** |
| Shares of common stock issued <sup>(1)</sup> | 1757815 |
| Weighted average price per share | $16.32 |
| Gross proceeds | $28694 |
| Sales commissions and offering costs | $342 |
| Net proceeds | $28352 |

---

<sup>(1)</sup> Includes 1,105,299 shares of common stock that were physically settled at a weighted-average price of $16.37 per share under forward sale agreements.

**Results of Operations**

*Overall*

We continued to grow our assets held for investment during the nine months ended September 30, 2025 through the acquisition of properties, property developments, and investment in mortgage loans receivable, with an underwritten weighted-average capitalization rate of approximately 7.6%. This growth was financed through the PNC Term Loan Agreement and receipt of proceeds of $200.0 million and $100.0 million under the 2031 Term Loan and 2032 Term Loan, respectively, the amendment of our PNC Credit Agreement and receipt of proceeds under our $175.0 million senior unsecured term loan (the "2030 Term Loan B"), settlement of shares of common stock through our forward sale agreements in an amount of $17.9 million, the issuance of common stock under the 2024 ATM Program in an amount of $10.5 million, the usage of cash balances as a result of borrowings on our Revolver, the usage of restricted cash balances as a result of tax-free exchanges under Section 1031 of the Internal Revenue Code of 1986, and cash flows from operations during the nine months ended September 30, 2025.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

*Acquisitions*

During the three months ended September 30, 2025, we acquired 46 properties for a total purchase price of $194.3 million, inclusive of $2.3 million of capitalized acquisition costs. The acquisitions were all accounted for as asset acquisitions. These properties are located in 20 states with a WALT of approximately 13.4 years.

During the nine months ended September 30, 2025, we acquired 87 properties for a total purchase price of $368.3 million, inclusive of $4.2 million of capitalized acquisition costs. The acquisitions were all accounted for as asset acquisitions. These properties are located in 28 states with a WALT of approximately 13.1 years.

*Development*

As of September 30, 2025, we had two property developments under construction. During the three and nine months ended September 30, 2025, we invested $0.1 million and $2.2 million, respectively, in property developments. During the nine months ended September 30, 2025, we completed development on two projects and reclassified approximately $6.5 million from property under development to land, buildings and improvements, and other assets (leasing commissions) in the accompanying condensed consolidated balance sheets. Rent commenced for both of the completed developments in the second quarter of 2025. The remaining two developments are expected to be substantially completed with rent commencing at various points throughout 2026. The purchase price, including acquisition costs, and subsequent development are included in property under development in the accompanying condensed consolidated balance sheets as of September 30, 2025.

*Dispositions*

During the three months ended September 30, 2025, we sold 24 properties for a total sales price, net of disposal costs, of $36.0 million, recognizing a net gain of $1.1 million on the sales. During the nine months ended September 30, 2025, we sold 60 properties for a total sales price, net of disposal costs, of $130.2 million, recognizing a net gain of $6.7 million on the sales.

*Investment in Mortgage Loans Receivable*

During the three and nine months ended September 30, 2025, we invested an additional $9.6 million and $35.3 million, respectively, in fully collateralized mortgage loans receivable with stated interest rates ranging from 7.00% to 10.25%. In addition, during the three and nine months ended September 30, 2025, we collected $12.5 million and $24.7 million, respectively, in principal on our mortgage loans receivable. Additionally, we sold three mortgage loans receivable at a discount in an effort to manage tenant exposure, recognizing non-credit related provisions for impairment of $1.4 million for the three and nine months ended September 30, 2025. See discussion of our mortgage loans receivable portfolio included in "Note 4 – Real Estate Investments" of our condensed consolidated financial statements, included in "Item 1 – Financial Statements (unaudited)".

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

*Economic and Financial Environment*

Changes in global or national market and economic conditions, such as global economic and financial market volatility and global geopolitical conflict, have caused, and may continue to cause, among other things, tightening in the credit markets, lower levels of liquidity, fluctuating interest rates and inflation, increases in the rate of default and bankruptcy, and lower consumer and business spending, which could materially and adversely affect us. For example, the current and continuing macro-economic conditions, including variable inflation and changing interest rates, may increase the costs associated with acquiring new properties and decrease the availability of financing on terms that we find attractive, which could reduce our ability to acquire properties at our historical rate with attractive terms. Additionally, other macroeconomic pressures in the U.S. and the global economy, including new and proposed tariffs on imports into the United States and current and potential countermeasures by foreign governments and recession fears, may impact our tenants as consumers reduce discretionary spending. A decline in consumer spending has had and may continue to have an adverse effect on tenants which, in turn, could impact our performance if tenants terminate leases or otherwise fail to pay rents. Other potential consequences of changes in economic and financial conditions include: changes in the performance of our tenants, which may result in lower rent and lower recoverable expenses, and tenant defaults under the lease; current or potential tenants may delay or postpone entering into long-term leases with us; increased costs of acquiring new properties on attractive terms; inability to borrow on terms and conditions that we find to be acceptable, which could reduce our ability to pursue acquisition opportunities or increase future interest expense; and the recognition of impairment charges on or reduced values of our properties, which may adversely affect our results of operations or limit our ability to dispose of assets at attractive prices and may reduce the availability of buyer financing. We are also limited in our ability to reduce costs to offset the results of a prolonged or severe economic downturn given certain fixed costs and commitments associated with our operations. We continually monitor the commercial real estate and credit markets carefully and, if required, will make decisions to adjust our business strategy accordingly.

***Three Months Ended September 30, 2025 Compared with Three Months Ended September 30, 2024***

The following table sets forth our operating results for the periods indicated (in thousands):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** |
| | **2025** | **2024** |
| **Revenues** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Rental revenue (including reimbursable) | $45026 | $38172 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income on loans receivable | 3282 | 3272 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 48308 | 41444 |
| **Operating expenses** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Property | 4302 | 4494 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 5128 | 4287 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 21389 | 20438 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provisions for impairment | 5493 | 9838 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction costs | 19 | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 36331 | 39083 |
| **Other (expense) income** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (12636) | (7965) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain (loss) on sales of real estate, net | 1122 | (132) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income, net | 170 | 416 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense, net | (11344) | (7681) |
| Net income (loss) before income taxes | 633 | (5320) |
| Income tax expense | (12) | (2) |
| **Net income (loss)** | $621 | $(5322) |

---

*Revenue.* Revenue for the three months ended September 30, 2025 increased by $6.9 million to $48.3 million from $41.4 million for the three months ended September 30, 2024, which is primarily attributed to an increase in the number of our operating leases. The increase includes additional cash rental receipts of $5.8 million, combined net increases of property expense reimbursements of $0.7 million, and an increase of $0.4 million in straight-line rental revenue.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

*Total operating expenses.* Total operating expenses decreased by $2.8 million to $36.3 million for the three months ended September 30, 2025 as compared to $39.1 million for the three months ended September 30, 2024. The decrease is primarily attributed to a decrease in provisions for impairment, partially offset by increases in depreciation and amortization expense and payroll-related expenses. Total operating expenses include the following:

• *Property expenses.* Property expenses decreased by $0.2 million to $4.3 million for the three months ended September 30, 2025 from $4.5 million for the three months ended September 30, 2024. The decrease is primarily attributed to combined net decreases of reimbursable property expenses of $0.2 million, of which $0.4 million were related to reimbursable common area maintenance and $0.1 million were related to reimbursable insurance, partially offset by an increase of $0.3 million of reimbursable property taxes.

• *General and administrative expenses.* General and administrative expenses increased by $0.8 million to $5.1 million for the three months ended September 30, 2025 from $4.3 million for the three months ended September 30, 2024. The increases within general and administrative expense were primarily related to an increase of $0.6 million of bonus expense and an increase of $0.2 million of payroll expense. While our general and administrative expenses will continue to rise in some measure as our portfolio grows, we expect that such expenses, as a percentage of our portfolio ABR and total assets, will decrease over time due to operating efficiencies and economies of scale.

• *Depreciation and amortization.* Depreciation and amortization expense increased by $1.0 million to $21.4 million for the three months ended September 30, 2025 from $20.4 million for the three months ended September 30, 2024. The increase in depreciation and amortization is proportionate to the increase in the size of the portfolio over the comparable period with associated increases primarily in building depreciation expense of $0.6 million, building improvements depreciation expense of $0.3 million, and in-place lease amortization expense of $0.1 million.

• *Provisions for impairment.* For the three months ended September 30, 2025, we recorded provisions for impairment of $5.5 million on 13 properties and three mortgage loans receivable, the majority of which were either previously classified as held-for-sale, newly classified as held-for-sale, or disposed during the three months ended September 30, 2025. One of the properties was held for investment as of September 30, 2025. For the three months ended September 30, 2024, we recorded provisions for impairment of $9.8 million on 18 properties, the majority of which were classified as held-for-sale or disposed during the three months ended September 30, 2024. Three of the properties were held for investment as of September 30, 2024. Property disposals relate to management's continuous assessment of the Company's portfolio in an effort to improve returns and manage risk exposure.

*Interest expense, net.* Interest expense increased by $4.6 million to $12.6 million for the three months ended September 30, 2025 from $8.0 million for the three months ended September 30, 2024. The increase is primarily attributable to an increase of $2.7 million of interest related to our term loans, of which $2.3 million was related to our new 2030 Term Loan B, an increase of $1.7 million in amortization of deferred losses on interest rate swaps, and an increase of $0.2 million in amortization of loan fees associated with the January 2025 debt transactions.

*Gain (loss) on sales of real estate, net.* Net gain (loss) on sales of real estate increased by $1.2 million to a $1.1 million gain for the three months ended September 30, 2025 from a $0.1 million loss for the three months ended September 30, 2024. For the three months ended September 30, 2025, 24 properties were sold for a sales price, net of disposal costs, of $36.0 million. For the three months ended September 30, 2024, eight properties were sold for a sales price, net of disposal costs, of $23.0 million.

*Other income, net.* Other income, net decreased by $0.2 million to $0.2 million for the three months ended September 30, 2025 from $0.4 million for the three months ended September 30, 2024. The decrease is primarily related to a $0.2 million reduction in insurance recoveries associated with prior year property damages and an increase of $0.1 million of third-party debt issuance costs expensed as a result of the September 2025 debt transactions.

*Net income (loss).* Net income increased by $5.9 million to net income of $0.6 million for the three months ended September 30, 2025 from a net loss of $5.3 million for the three months ended September 30, 2024. Net income increased primarily due to additional rental revenues associated with the growth of our real estate investment portfolio, an increase in the net gain on the sales of real estate, and a decrease of provisions for impairment. These increases are partially offset by increases in interest expense, depreciation and amortization expense, and bonus and payroll-related expenses.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

***Nine Months Ended September 30, 2025 Compared with Nine Months Ended September 30, 2024***

The following table sets forth our operating results for the periods indicated (in thousands):

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| **Revenues** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Rental revenue (including reimbursable) | $132774 | $110226 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income on loans receivable | 9485 | 8458 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other revenue | 245 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 142504 | 118684 |
| **Operating expenses** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Property | 13589 | 12578 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 15772 | 15266 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 63818 | 56522 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provisions for impairment | 13531 | 17336 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction costs | 139 | 201 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 106849 | 101903 |
| **Other (expense) income** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (36734) | (21749) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sales of real estate, net | 6730 | 874 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on debt extinguishment | (46) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income (expense), net | 46 | (2451) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense, net | (30004) | (23326) |
| Net income (loss) before income taxes | 5651 | (6545) |
| Income tax expense | (41) | (31) |
| **Net income (loss)** | $5610 | $(6576) |

---

*Revenue.* Revenue for the nine months ended September 30, 2025 increased by $23.8 million to $142.5 million from $118.7 million for the nine months ended September 30, 2024, which is attributed to an increase in the number of our operating leases and properties securing our mortgage loans. The increase includes additional cash rental receipts of $19.3 million, combined net increases of property expense reimbursements of $1.9 million, an increase of $1.4 million in straight-line rental revenue, an increase of $1.0 million related to interest income on mortgage loans receivable, and an increase of $0.2 million of other revenue related to settlement proceeds associated with a lease termination.

*Total operating expenses.* Total expenses increased by $4.9 million to $106.8 million for the nine months ended September 30, 2025 as compared to $101.9 million for the nine months ended September 30, 2024. The increase is primarily attributed to an increase in the number of operating properties, with the most significant increases being depreciation and amortization expense, property-specific reimbursable expenses, and payroll-related costs, offset by a decrease in employee severance and a decrease in provisions for impairment. Total operating expenses include the following:

• *Property expenses.* Property expenses increased by $1.0 million to $13.6 million for the nine months ended September 30, 2025 from $12.6 million for the nine months ended September 30, 2024. The increase is primarily attributed to the increase in the number of operating properties, including combined net increases of reimbursable property expenses of $0.6 million, of which $1.1 million were related to reimbursable property taxes, which were offset by decreases of $0.3 million and $0.2 million of reimbursable common area maintenance and reimbursable insurance, respectively, and combined net increases of non-reimbursable property expenses of $0.4 million, of which $0.3 million were related to property insurance.

• *General and administrative expenses.* General and administrative expenses increased by $0.5 million to $15.8 million for the nine months ended September 30, 2025 from $15.3 million for the nine months ended September 30, 2024. The increase is primarily due to an increase of $1.3 million of bonus expense, an increase of $0.3 million of stock-based compensation, and other net increases of $0.3 million, partially offset by a decrease of employee severance of $1.4 million. While our general and administrative expenses will continue to rise in some measure as our portfolio grows, we expect that such expenses, as a percentage of our portfolio ABR and total assets, will decrease over time due to operating efficiencies and economies of scale.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

• *Depreciation and amortization.* Depreciation and amortization expense increased by $7.3 million to $63.8 million for the nine months ended September 30, 2025 from $56.5 million for the nine months ended September 30, 2024. The increase in depreciation and amortization is proportionate to the increase in the size of the portfolio over the comparable period with associated increases primarily in building depreciation expense of $4.1 million, building improvements depreciation expense of $2.0 million, and in-place lease amortization expense of $1.2 million.

• *Provisions for impairment.* For the nine months ended September 30, 2025, we recorded provisions for impairment of $13.5 million on 34 properties and three mortgage loans receivable, the majority of which were either previously classified as held-for-sale, newly classified as held-for-sale, or disposed during the nine months ended September 30, 2025. Two properties were held for investment as of September 30, 2025. For the nine months ended September 30, 2024, we recorded provisions for impairment of $17.3 million on 40 properties, the majority of which were either previously classified as held-for-sale, newly classified as held-for-sale, or disposed during the nine months ended September 30, 2024. Nine properties were held for investment as of September 30, 2024. Property disposals relate to management's continuous assessment of the Company's portfolio in an effort to improve returns and manage risk exposure.

*Interest expense, net.* Interest expense increased by $15.0 million to $36.7 million for the nine months ended September 30, 2025 from $21.7 million for the nine months ended September 30, 2024. The increase is primarily attributable to an increase of $8.1 million of interest related to our term loans, of which $6.5 million, $0.8 million, and $0.7 million is related to our new 2030 Term Loan B, our $250.0 million senior unsecured term loan (the "2029 Term Loan"), and our $175.0 million senior unsecured term loan (the "2030 Term Loan A"), respectively. Additional increases are related to an increase of $5.1 million in amortization of deferred losses on interest rate swaps, an increase of $0.7 million of interest incurred under our Revolver, primarily due to an increase in average borrowings outstanding, an increase of $0.6 million of capitalized interest on our property developments, and an increase of $0.5 million in amortization of loan fees associated with the January 2025 debt transactions.

*Gain on sales of real estate, net.* Net gain on sales of real estate increased by $5.8 million to $6.7 million for the nine months ended September 30, 2025 from $0.9 million for the nine months ended September 30, 2024. For the nine months ended September 30, 2025, 60 properties were sold for a sales price, net of disposal costs, of $130.2 million. For the nine months ended September 30, 2024, 26 properties were sold for a sales price, net of disposal costs, of $55.6 million.

*Other income (expense), net.* Other income (expense), net decreased by $2.5 million to less than $0.1 million of other income for the nine months ended September 30, 2025 from $2.5 million of other expense for the nine months ended September 30, 2024. The net decrease in expense is primarily related to events that occurred during the nine months ended September 30, 2024, including a transfer fraud loss of $2.8 million, net of insurance recoveries, and $0.9 million of losses associated with property damages offset by $0.2 million of insurance recoveries, partially offset by $0.5 million of proceeds received from the settlement of a lease escrow agreement during the nine months ended September 30, 2024 and $0.4 million and $0.1 million of third-party debt issuance costs expensed as a result of the January 2025 and September 2025 debt transactions.

*Net income (loss).* Net income increased by $12.2 million to net income of $5.6 million for the nine months ended September 30, 2025 from a net loss of $6.6 million for the nine months ended September 30, 2024. Net income increased due to additional rental revenues associated with the growth of our real estate investment portfolio, in addition to increased interest income associated with our mortgage loans receivable, an increase in the net gain on the sales of real estate, a decrease in provisions for impairment, a decrease of employee severance, and the occurrence of a transfer fraud loss in the prior year. The increase in net income is partially offset by increases in interest expense and depreciation and amortization expense.

**Liquidity and Capital Resources**

Our primary capital requirements include funding property acquisitions and developments, investments in mortgage loans receivable, required debt interest payments, as well as working capital needs, operating expenses, and capital expenditures. Our capital resources primarily consist of cash from operations, sales of equity securities, and available borrowing facilities. As of September 30, 2025, we had $200.0 million outstanding principal amount under the $200.0 million senior unsecured term loan (the "2028 Term Loan"), $250.0 million outstanding principal amount under the 2029 Term Loan, $175.0 million outstanding principal amount under the 2030 Term Loan A, $175.0 million outstanding principal amount under the 2030 Term Loan B, $200.0 million outstanding principal amount under the 2031 Term Loan, and $100.0 million outstanding principal amount under the 2032 Term Loan. Additionally, as of September 30, 2025, we had $40.8 million and $30.2 million of unsettled forward equity under our 2024 ATM Program and prior at-the-market equity program, respectively. As of September 30, 2025, $271.3 million of remaining gross proceeds were available for future issuances of shares of our common stock under the 2024 ATM Program, inclusive of unsettled shares under forward sale agreements. Lastly, we had $150.5 million and $209.7 million of unsettled forward equity under the January 2024 and July 2025 follow-on offering forward sale agreements, respectively, as of September 30, 2025.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

On January 15, 2025, we amended our PNC Credit Agreement to provide for a new $175.0 million 2030 Term Loan B and an upsized $500.0 million Revolver. The 2030 Term Loan B and the upsized Revolver initially mature in January 2029 and include, at our election, a one-year option to extend the maturity to January 2030. The 2030 Term Loan B was fully funded on the closing date and we have hedged the entire $175.0 million 2030 Term Loan B at an all-in fixed interest rate of 5.02% through January 2030. The Wells Fargo Credit Agreement was amended and restated to extend the maturity date of the existing $175.0 million 2030 Term Loan A from January 2027 to January 2029 with an option, at our election, to extend the maturity to January 2030.

On September 25, 2025, we entered into a PNC Term Loan Agreement to provide for a new $200.0 million 2031 Term Loan, which was fully funded on the closing date, and a $250.0 million 2032 Term Loan, of which $100.0 million was funded on the closing date and the remaining $150.0 million will be available until September 25, 2026. The 2031 Term Loan matures on March 25, 2031 and the 2032 Term Loan matures on September 24, 2032. We have hedged the entire $200.0 million 2031 Term Loan at an all-in fixed interest rate of 4.59% through March 2031. We have partially hedged $200.0 million of the 2032 Term Loan at an all-in fixed interest rate of 4.92% through September 2032, with the remaining $50.0 million of the 2032 Term Loan currently unhedged.

We believe the availability of proceeds from our debt, proceeds from the settlement of unsettled outstanding forward sale agreements, future issuances of shares of our common stock under our ATM program or subsequent at-the-market sale programs, as well as our cash flows from operations and available borrowing capacity under the Revolver, will be adequate to support our ongoing operations and to fund our debt service requirements, capital expenditures, and working capital requirements for at least the next 12 months. We anticipate funding our long-term capital needs through cash provided from operations, borrowings under our 2032 Term Loan, borrowings under our Revolver, and issuances of common stock.

*Contractual Obligations and Commitments*

As of September 30, 2025, our contractual debt obligations primarily include the maturity of our 2028 Term Loan with the scheduled principal payment due on February 11, 2028, the maturity of our 2029 Term Loan with the scheduled principal payment due on July 3, 2026, the maturities of our 2030 Term Loan A and 2030 Term Loan B with the scheduled principal payments due on January 15, 2029, the maturity of our 2031 Term Loan with the scheduled principal payment due on March 25, 2031, and the maturity of our 2032 Term Loan with the scheduled principal payment due on September 24, 2032. During the nine months ended September 30, 2025, we borrowed $199.0 million at a weighted average interest rate of 5.47% and also repaid $438.0 million on our Revolver.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

The following table provides information with respect to our commitments as of September 30, 2025 (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** |
| | **Total** | **From October 1, 2025 to December 31, 2025** | **2026 - 2027** | **2028 - 2029** | **Thereafter** |
| **Contractual Obligations** | | | | | |
| 2028 Term Loan – Principal | $200000 | $— | $— | $200000 | $— |
| 2028 Term Loan – Variable interest <sup>(1)</sup> | 17895 | 1906 | 15121 | 868 |  |
| 2029 Term Loan – Principal | 250000 |  | 250000 |  |  |
| 2029 Term Loan – Variable interest <sup>(1)</sup> | 9236 | 3079 | 6157 |  |  |
| 2030 Term Loan A – Principal | 175000 |  |  | 175000 |  |
| 2030 Term Loan A – Variable interest <sup>(1)</sup> | 20437 | 1564 | 12412 | 6461 |  |
| 2030 Term Loan B – Principal | 175000 |  |  | 175000 |  |
| 2030 Term Loan B – Variable interest <sup>(1)</sup> | 28953 | 2216 | 17584 | 9153 |  |
| 2031 Term Loan – Principal | 200000 |  |  |  | 200000 |
| 2031 Term Loan – Variable interest <sup>(1)</sup> | 50296 | 2312 | 18349 | 18349 | 11286 |
| 2032 Term Loan – Principal | 100000 |  |  |  | 100000 |
| 2032 Term Loan – Variable interest <sup>(1)</sup> | 34541 | 1247 | 9891 | 9891 | 13512 |
| Ticking Fee <sup>(2)</sup> | 225 | 5 | 220 |  |  |
| Facility Fee <sup>(3)</sup> | 2470 | 189 | 1500 | 781 |  |
| Mortgage Note – Principal | 8084 | 43 | 8041 |  |  |
| Mortgage Note – Interest | 772 | 91 | 681 |  |  |
| Property development under contract | 6269 | 1740 | 4529 |  |  |
| Additional principal under mortgage loans receivable | 11403 | 4778 | 6625 |  |  |
| Tenant improvement allowances | 6339 | 3599 | 2740 |  |  |
| Corporate office lease obligations | 4795 | 161 | 1323 | 1396 | 1915 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $1301715 | $22930 | $355173 | $596899 | $326713 |

---

<sup>(1)</sup> We have various interest rate derivative contracts to fix the variable base interest rate (SOFR) on our term loans. Accordingly, the projected interest rate obligations for the variable rate term loans are based on the weighted-average hedged fixed rates, plus the applicable margins. See "Note 6 – Debt" and "Note 7 – Derivative Financial Instruments" for further discussion on our debt and interest rate hedges.

<sup>(2)</sup> We are subject to a ticking fee of 0.20% on the undrawn amount under our 2032 Term Loan.

<sup>(3)</sup> We are subject to a facility fee of 0.15% on our Revolver.

In August 2021, we entered into a lease agreement related to our corporate office space, which is classified as an operating lease. We began operating out of the office in February 2022. The lease has a remaining noncancellable term of 6.8 years that expires on July 31, 2032 and is renewable at our option for two additional periods of five years. Annual rent expense, excluding operating expenses, is approximately $0.5 million during the initial term.

Additionally, in the normal course of business, we enter into various types of commitments to purchase real estate properties, fund development projects, or extend funds under mortgage loans receivable. These commitments are generally subject to our customary due diligence process and, accordingly, a number of specific conditions must be met before we are obligated to purchase or extend funding. As of September 30, 2025, we had commitments to fund property developments and extend funds under mortgage loans receivable totaling $6.3 million and $11.4 million, respectively, which is expected to be funded through the end of 2026.

*Debt*

See discussion of our debt and interest rate hedges included in "Note 6 – Debt" and "Note 7 – Derivative Financial Instruments" in "Item 1 – Financial Statements (unaudited)."

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

***Historical Cash Flow Information***

***Nine Months Ended September 30, 2025 Compared with Nine Months Ended September 30, 2024***

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** |
| **(In thousands)** | **(Unaudited)** | **(Unaudited)** |
| Net cash provided by (used in): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating activities | $80701 | $62128 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investing activities | (239508) | (319379) |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing activities | 197811 | 256072 |

---

*Cash Flows Provided By Operating Activities.* Net cash provided by operating activities increased by $18.6 million for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The increase was largely attributed to the increase in the size of our real estate investment portfolio with an increase in rental receipts of $19.3 million, additional interest received under our mortgage loans receivable, and changes in working capital accounts, partially offset by an increase in cash paid for interest of $9.1 million, and an increase in operating expenses paid associated with our larger portfolio.

*Cash Flows Used In Investing Activities.* Net cash used in investing activities decreased by $79.9 million for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The decrease was primarily due to an increase of $78.9 million and $10.5 million of proceeds received from the sale of real estate and mortgage loans receivable, respectively, a decrease of $33.3 million in real estate development and improvements, an increase of $13.4 million in principal collections on mortgage loans receivable, and a decrease of $7.5 million in earnest money deposits, partially offset by an increase of $62.9 million in acquisitions of real estate and an increase in cash invested in mortgage loans receivable of $0.5 million.

*Cash Flows Provided By Financing Activities.* Net cash provided by financing activities decreased by $58.3 million for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The decrease was primarily attributed to an increase in net repayments of $309.0 million under our Revolver and $107.1 million of less proceeds received due to fewer issuances of common stock in connection with our ATM Programs and forward sale agreements. Additional items contributing to the decrease are an increase of $12.0 million in deferred financing costs and an increase in payments of common stock dividends of $6.0 million. The decrease is partially offset by an increase in net term loan proceeds of $375.0 million, and a decrease in the repurchase of common stock for tax withholding obligations of $0.6 million.

***Income Taxes***

We have elected to be treated and qualify as a REIT for U.S. federal income tax purposes. To qualify as a REIT, we must meet certain organizational, income, asset, and distribution tests. Accordingly, we will generally not be subject to corporate U.S. federal or state income tax to the extent that we make qualifying distributions of all of our taxable income to our stockholders and provided we satisfy on a continuing basis, through actual investment and operating results, the REIT requirements, including certain asset, income, distribution, and share ownership tests. We intend to make sufficient distributions during 2025 to receive a full dividends paid deduction.

We maintain a taxable REIT subsidiary ("TRS") which may be subject to U.S. federal, state, and local income taxes on its taxable income. In general, our TRS may perform services for our tenants, hold assets that we cannot hold directly, and may engage in any real estate or non-real estate-related business.

***Recent Accounting Pronouncements***

A discussion of recent accounting pronouncements and their possible effects on our condensed consolidated financial statements is included in "Note 2 – Summary of Significant Accounting Policies" in "Item 1 – Financial Statements (unaudited)."

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**Critical Accounting Policies and Estimates**

Our accounting policies have been established to conform with U.S. GAAP. The preparation of financial statements in conformity with U.S. GAAP requires us to use judgment in the application of accounting policies, including making estimates and assumptions. These judgments affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that we have made these estimates and assumptions in an appropriate manner and in a way that accurately reflects our financial condition. We continually test and evaluate these estimates and assumptions using our historical knowledge of the business, as well as other factors, to ensure that they are reasonable for reporting purposes. However, actual results may differ from these estimates and assumptions. If our judgment or interpretation of the facts and circumstances relating to the various transactions had been different, it is possible that different accounting policies would have been applied, thus resulting in a different presentation of the financial statements. Additionally, other companies may utilize different estimates that may impact comparability of our results of operations to those of companies in similar businesses. A summary of our critical accounting policies is included in the section entitled "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2024, which is accessible on the SEC's website at www.sec.gov. There have been no material changes to these policies during the periods covered by this quarterly report.

**Non-GAAP Financial Measures**

Our reported results are presented in accordance with GAAP. We also disclose the following non-GAAP financial measures: Funds From Operations ("FFO"), Core FFO, Adjusted FFO ("AFFO"), earnings before interest expense, income tax expense, and depreciation and amortization ("EBITDA"), EBITDA further adjusted to exclude gains (or losses) from the sales of depreciable property and real estate impairment losses ("EBITDA*re*"), Adjusted EBITDA*re*, Annualized Adjusted EBITDA*re*, Net Debt, Adjusted Net Debt, property-level net operating income ("Property-Level NOI"), property-level cash net operating income ("Property-Level Cash NOI"), and property-level cash net operating income estimated run rate ("Property-Level Cash NOI - Estimated Run Rate"), all of which are detailed below. We believe these non-GAAP financial measures are industry measures used by analysts and investors to compare the operating performance of REITs.

***FFO, Core FFO, and AFFO***

The National Association of Real Estate Investment Trusts ("NAREIT"), an industry trade group, has promulgated a widely accepted non-GAAP financial measure of operating performance known as FFO. Our FFO is net income in accordance with GAAP, excluding gains (or losses) resulting from dispositions of properties, plus depreciation and amortization and impairment charges on depreciable real property.

Core FFO is a non-GAAP financial measure defined as FFO adjusted to remove the effect of unusual and non-recurring items that are not expected to impact our operating performance or operations on an ongoing basis. These include non-recurring executive transition costs, severance and related charges, other non-recurring losses (gains), and debt related transaction costs.

AFFO is a non-GAAP financial measure defined as Core FFO adjusted for GAAP net income related to non-cash revenues and expenses, such as straight-line rent, amortization of above- and below-market lease-related intangibles, amortization of lease incentives, capitalized interest expense and earned development interest, non-cash interest expense, non-cash compensation expense, amortization of deferred financing costs, amortization of above/below-market assumed debt, and amortization of loan origination costs.

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. In fact, real estate values historically have risen or fallen with market conditions. FFO is intended to be a standard supplemental measure of operating performance that excludes historical cost depreciation and valuation adjustments from net income. We consider FFO to be useful in evaluating potential property acquisitions and measuring operating performance.

We further consider FFO, Core FFO, and AFFO to be useful in determining funds available for payment of distributions. FFO, Core FFO, and AFFO do not represent net income or cash flows from operations as defined by GAAP. You should not consider FFO, Core FFO, and AFFO to be alternatives to net income as a reliable measure of our operating performance nor should you consider FFO, Core FFO, and AFFO to be alternatives to cash flows from operating, investing, or financing activities (as defined by GAAP) as measures of liquidity.

FFO, Core FFO, and AFFO do not measure whether cash flow is sufficient to fund our cash needs, including principal amortization, capital improvements, and distributions to stockholders. FFO, Core FFO, and AFFO do not represent cash flows

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

from operating, investing, or financing activities as defined by GAAP. Further, FFO, Core FFO, and AFFO as disclosed by other REITs might not be comparable to our calculations of FFO, Core FFO, and AFFO.

The following table sets forth a reconciliation of FFO, Core FFO, and AFFO for the periods presented to net income (loss) before allocation to noncontrolling interests, as computed in accordance with GAAP (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| Net income (loss) | $621 | $(5322) | $5610 | $(6576) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization of real estate | 21315 | 20360 | 63598 | 56286 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions for impairment | 4134 | 9838 | 12173 | 17336 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on sales of real estate, net | (1122) | 132 | (6730) | (874) |
| FFO | 24948 | 25008 | 74651 | 66172 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-recurring executive transition costs, severance, and related charges | 1 | 14 | 80 | 1495 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Debt related transaction costs | 92 |  | 495 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring loss (gain), net | 1314 | (115) | 1314 | 3077 |
| Core FFO | 26355 | 24907 | 76540 | 70744 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Straight-line rent adjustments | (1126) | (749) | (3263) | (1829) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred financing costs | 756 | 558 | 2164 | 1673 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of above/below-market assumed debt | 29 | 29 | 86 | 86 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of loan origination costs and discounts | (147) | (265) | (197) | (242) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of lease-related intangibles | (35) | (170) | (110) | (363) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earned development interest | 36 | 259 | 118 | 962 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capitalized interest expense | (24) | (130) | (112) | (709) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash interest expense (income) | 721 | (990) | 2138 | (2948) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash compensation expense | 1484 | 1376 | 4393 | 4128 |
| AFFO | $28049 | $24825 | $81757 | $71502 |

---

***EBITDA, EBITDAre, Adjusted EBITDAre, and Annualized Adjusted EBITDAre***

We compute EBITDA as earnings before interest expense, income tax expense, and depreciation and amortization. In 2017, NAREIT issued a white paper recommending that companies that report EBITDA also report EBITDA*re*. We compute EBITDA*re* in accordance with the definition adopted by NAREIT. NAREIT defines EBITDA*re* as EBITDA (as defined above) excluding gains (or losses) from the sales of depreciable property and impairment charges on depreciable real property.

Adjusted EBITDA*re* is a non-GAAP financial measure defined as EBITDA*re* further adjusted to exclude straight-line rent, non-cash compensation expense, non-recurring executive transition costs, severance and related charges, debt related transaction costs, transaction costs, other non-recurring loss (gain), net, other non-recurring expenses (income) including lease termination fees, as well as adjustments for construction in process and for intraquarter activities. Annualized Adjusted EBITDA*re* is Adjusted EBITDA*re* multiplied by four.

We present EBITDA, EBITDA*re*, Adjusted EBITDA*re*, and Annualized Adjusted EBITDA*re* as they are measures commonly used in our industry. We believe that these measures are useful to investors and analysts because they provide supplemental information concerning our operating performance, exclusive of certain non-cash items and other costs. We use EBITDA, EBITDA*re*, Adjusted EBITDA*re*, and Annualized Adjusted EBITDA*re* as measures of our operating performance and not as measures of liquidity.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

EBITDA, EBITDA*re*, Adjusted EBITDA*re*, and Annualized Adjusted EBITDA*re* do not include all items of revenue and expense included in net income, they do not represent cash generated from operating activities and they are not necessarily indicative of cash available to fund cash requirements; accordingly, they should not be considered alternatives to net income as a performance measure or cash flows from operations as a liquidity measure and should be considered in addition to, and not in lieu of, GAAP financial measures. Additionally, our computation of EBITDA, EBITDA*re*, Adjusted EBITDA*re*, and Annualized Adjusted EBITDA*re* may differ from the methodology for calculating these metrics used by other equity REITs and, therefore, may not be comparable to similarly titled measures reported by other equity REITs.

The following table sets forth a reconciliation of EBITDA and EBITDA*re* for the periods presented to net income (loss) before allocation to noncontrolling interests, as computed in accordance with GAAP (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| Net income (loss) | $621 | $(5322) | $5610 | $(6576) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization of real estate | 21315 | 20360 | 63598 | 56286 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of lease-related intangibles | (35) | (170) | (110) | (363) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-real estate depreciation and amortization | 74 | 78 | 220 | 236 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | 12636 | 7965 | 36734 | 21749 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | 12 | 2 | 41 | 31 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of loan origination costs and discounts | (147) | (265) | (197) | (242) |
| EBITDA | 34476 | 22648 | 105896 | 71121 |
| &nbsp;&nbsp;Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions for impairment | 4134 | 9838 | 12173 | 17336 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on sales of real estate, net | (1122) | 132 | (6730) | (874) |
| EBITDA*re* | $37488 | $32618 | $111339 | $87583 |

---

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

The following table sets forth a reconciliation of EBITDA, EBITDA*re*, Adjusted EBITDA*re*, and Annualized Adjusted EBITDA*re* for the period presented to net income before allocation to noncontrolling interests, as computed in accordance with GAAP (dollars in thousands):

---

| | |
|:---|:---|
| | **Three Months Ended September 30, 2025** |
| | **(Unaudited)** |
| Net income | $621 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization of real estate | 21315 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of lease-related intangibles | (35) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-real estate depreciation and amortization | 74 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | 12636 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of loan origination costs and discounts | (147) |
| EBITDA | 34476 |
| &nbsp;&nbsp;Adjustments: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions for impairment | 4134 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sales of real estate, net | (1122) |
| EBITDA*re* | 37488 |
| &nbsp;&nbsp;Adjustments: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Straight-line rent adjustments | (1126) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Debt related transaction costs | 92 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-recurring executive transition costs, severance, and related charges | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring loss, net | 1314 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction costs | 19 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash compensation expense | 1484 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustment for construction in process <sup>(1)</sup> | 32 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustment for intraquarter investment activities <sup>(2)</sup> | 2474 |
| Adjusted EBITDA*re* | 41778 |
| Annualized Adjusted EBITDA*re* <sup>(3)</sup> | $167112 |
| Net Debt / Annualized Adjusted EBITDAre | 6.3x |
| Adjusted Net Debt / Annualized Adjusted EBITDA*re* | 3.7x |
| Pro Forma Adjusted Net Debt / Annualized Adjusted EBITDA*re* | 3.6x |

---

<sup>(1)</sup> Adjustment reflects the estimated cash yield on developments in process as of September 30, 2025.

<sup>(2)</sup> Adjustment assumes all re-leasing activity, investments in and dispositions of real estate, including developments completed during the three months ended September 30, 2025 had occurred on July 1, 2025.

<sup>(3)</sup> We calculate Annualized Adjusted EBITDA*re* by multiplying Adjusted EBITDA*re* by four.

***Net Debt, Adjusted Net Debt, and Pro Forma Adjusted Net Debt***

We calculate Net Debt as the principal amount of our total debt outstanding, excluding deferred financing costs, net discounts, and debt issuance costs, less cash, cash equivalents, and restricted cash available for future investment.

We then adjust Net Debt by the net value of unsettled forward equity as of period end to derive Adjusted Net Debt. Further, we adjust Adjusted Net Debt by the value of any unsettled forward equity and at-the-market sales occurring subsequent to the period to derive Pro Forma Adjusted Net Debt.

We believe excluding cash, cash equivalents, and restricted cash available for future investment from the principal amount of our total debt outstanding, together with the exclusion of the net value of unsettled forward equity as of period end and the net value of unsettled forward equity and at-the-market sales subsequent to the period, all of which could be used to repay debt, provides a useful estimate of the net contractual amount of borrowed capital to be repaid. We believe these adjustments are additional beneficial disclosures to investors and analysts.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

The following table reconciles the principal amount of total debt to Net Debt, Adjusted Net Debt, and Pro Forma Adjusted Net Debt (in thousands):

---

| | |
|:---|:---|
| | **As of**<br>**September 30, 2025** |
| Principal amount of total debt | $1108084 |
| Less: Cash, cash equivalents, and restricted cash | (53324) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Debt | 1054760 |
| Less: Net value of unsettled forward equity <sup>(1)</sup> | (431246) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted Net Debt | 623514 |
| Less: Subsequent ATM sales <sup>(2)</sup> | (29682) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pro Forma Adjusted Net Debt | $593832 |

---

<sup>(1)</sup> There were 25,393,242 unsettled shares under forward equity contracts as of September 30, 2025 at the available weighted-average net settlement price of $16.98.

<sup>(2)</sup> There were 1,556,592 unsettled shares under new forward equity contracts executed subsequent to the period at the available weighted-average net settlement price of $18.12. Additionally, there were 82,500 shares of common stock issued under the ATM program at a net settlement price of $17.96 per share.

***Property-Level NOI, Property-Level Cash NOI, and Property-Level Cash NOI - Estimated Run Rate***

Property-Level NOI, Property-Level Cash NOI, and Property-Level Cash NOI - Estimated Run Rate are non-GAAP financial measures which we use to assess our operating results. We compute Property-Level NOI as net income (computed in accordance with GAAP), excluding general and administrative expenses, interest expense, net, income tax expense, amortization of loan origination costs and discounts, transaction costs, depreciation and amortization, gains (or losses) on sales of depreciable property, real estate impairment losses, interest income on mortgage loans receivable, debt related transaction costs, and other expense (income), net, including lease termination fees. We further adjust Property-Level NOI for non-cash revenue components of straight-line rent and amortization of lease-intangibles to derive Property-Level Cash NOI. We further adjust Property-Level Cash NOI for intraquarter acquisitions, dispositions, and completed development to derive Property-Level Cash NOI - Estimated Run Rate. We believe Property-Level NOI, Property-Level Cash NOI, and Property-Level Cash NOI - Estimated Run Rate provide useful and relevant information because they reflect only those income and expense items that are incurred at the property level and present such items on an unlevered basis.

Property-Level NOI, Property-Level Cash NOI, and Property-Level Cash NOI - Estimated Run Rate are not measurements of financial performance under GAAP and may not be comparable to similarly titled measures of other companies. You should not consider our measures as alternatives to net income or cash flows from operating activities determined in accordance with GAAP.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

The following table sets forth a reconciliation of Property-Level NOI, Property-Level Cash NOI, and Property-Level Cash NOI - Estimated Run Rate for the period presented (in thousands):

---

| | |
|:---|:---|
| | **Three Months Ended September 30, 2025** |
| | **(Unaudited)** |
| Net income | $621 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative expense | 5128 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 21389 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provisions for impairment | 5493 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction costs | 19 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | 12636 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sales of real estate, net | (1122) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of loan origination costs and discounts | (147) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest income on mortgage loans receivable | (3282) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other income, net | (170) |
| Property-Level NOI | 40577 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Straight-line rent adjustments | (1126) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of lease-related intangibles | (35) |
| Property-Level Cash NOI | $39416 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustment for intraquarter acquisitions, dispositions, and completed development <sup>(1)</sup> | 2691 |
| Property-Level Cash NOI - Estimated Run Rate | $42107 |

---

<sup>(1)</sup> Adjustment assumes all re-leasing activity, investments in and dispositions of real estate, including developments completed during the three months ended September 30, 2025 had occurred on July 1, 2025.

**Item 3. *Quantitative and Qualitative Disclosures About Market Risk***

Our future income, cash flows, and fair value relevant to our financial instruments depend upon prevailing market interest rates. Market risk refers to the risk of loss from adverse changes in market prices and interest rates. Based upon the nature of our operations, the principal market risk to which we are exposed is the risk related to interest rate fluctuations. As of September 30, 2025, we had total indebtedness of $200.0 million under the 2028 Term Loan, $250.0 million under the 2029 Term Loan, $175.0 million under the 2030 Term Loan A, $175.0 million under the 2030 Term Loan B, $200.0 million under the 2031 Term Loan, and $100.0 million under the 2032 Term Loan, all of which are floating rate debt with a variable interest rate. For the three and nine months ended September 30, 2025, we had average daily outstanding borrowings on our Revolver of $111.7 million and $116.5 million, respectively.

We have entered into interest rate derivative contracts in order to hedge our market risk associated with the term loans. The 2028 Term Loan, 2029 Term Loan, 2030 Term Loan B, 2031 Term Loan, and 2032 Term Loan have interest rate hedges that coincide with the extended maturity dates of the loans. The 2030 Term Loan A interest rate hedge matures on January 23, 2027. The interest rate derivative contracts convert the variable rate debt on our term loans to a fixed interest rate (as further described in "Note 7 – Derivative Financial Instruments" in our condensed consolidated financial statements).

Additionally, we will occasionally fund acquisitions through the use of our Revolver which, as of September 30, 2025, bore an interest rate determined by either (i) SOFR, plus a margin ranging from 1.00% to 1.45%, based on our consolidated total leverage ratio, or (ii) a Base Rate (as defined in the PNC Credit Agreement), plus a margin ranging from 0.00% to 0.45%, based on our consolidated total leverage ratio. Many factors, including governmental monetary and tax policies, domestic and international economic and political considerations, and other factors that are beyond our control contribute to our interest rate risk. Based on the results of our sensitivity analysis and daily outstanding borrowings on the Revolver during 2025, which assumes a 1% adverse change in the interest rate as of September 30, 2025, the estimated market risk exposure was approximately $1.2 million.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**Item 4. *Controls and Procedures***

*Evaluation of Disclosure Controls and Procedures.*

At the end of the period covered by this report, the Company conducted an evaluation, under the supervision and with the participation of its principal executive officer and principal financial officer, of its disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, the Company's principal executive officer and principal financial officer concluded that its disclosure controls and procedures were effective as of September 30, 2025 to ensure that information required to be disclosed in reports that the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.

*Changes in Internal Control over Financial Reporting.*

During the period covered by this report, there were no changes to the Company's internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) identified in connection with the evaluation described above that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**PART II — OTHER INFORMATION**

**Item 1. *Legal Proceedings***

From time to time, we may be party to various lawsuits, claims, and other legal proceedings that arise in the ordinary course of our business. We are not currently subject to any material lawsuits, claims, or other legal proceedings.

**Item 1A. *Risk Factors***

For a discussion of the most significant factors that may adversely affect us, see the information under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024, which is accessible on the SEC's website at www.sec.gov. There have been no material changes to the risk factors disclosed in the Annual Report. These risk factors may not describe every risk facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, and results of operations.

**Item 2. *Unregistered Sales of Equity Securities and Use of Proceeds***

***Unregistered Sales of Equity Securities and Use of Proceeds***

None.

***Company Stock Repurchases***

None.

**Item 3. *Defaults Upon Senior Securities***

Not applicable.

**Item 4. *Mine Safety Disclosures***

Not applicable.

**Item 5. *Other Information***

Not applicable.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**Item 6. *Exhibits***

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 3.1 | <u>[Conformed Articles of Amendment and Restatement of NETSTREIT Corp. (incorporated by reference to Exhibit 3.1 to the Registrant's Annual Report on Form 10-K for the year ended December 31, 2022).](https://www.sec.gov/Archives/edgar/data/1798100/000179810023000008/conformed-netstreitxarticl.htm)</u> |
| 3.2 | <u>[Amended and Restated Bylaws of NETSTREIT Corp. (incorporated by reference to Exhibit 3.2 to the Registrant's Annual Report on Form 10-K for the year ended December 31, 2022).](https://www.sec.gov/Archives/edgar/data/1798100/000179810023000008/ntst-arbylawsfebruary2023x.htm)</u> |
| 10.1\*# | <u>[First Amendment to Second Amended and Restated Credit Agreement, dated as of September 25, 2025, by and among NETSTREIT, L.P., NETSTREIT Corp., the several institutions party thereto, as lenders, and Wells Fargo Bank, National Association, as Administrative Agent.](exhibit101-firstamendmen.htm)</u> |
| 31.1\* | <u>[Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ntstform3q25xex311x302xmark.htm)</u> |
| 31.2\* | <u>[Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ntstform3q25xex312x302xdan.htm)</u> |
| 32.1\* | <u>[Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ntstform3q25xex321x906xmark.htm)</u> |
| 32.2\* | <u>[Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ntstform3q25xex322x906xdan.htm)</u> |
| 101.INS\*\* | XBRL Instance Document. |
| 101.SCH\*\*\* | XBRL Taxonomy Extension Schema Document. |
| 101.CAL\*\*\* | XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.LAB\*\*\* | XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE\*\*\* | XBRL Taxonomy Extension Presentation Linkbase Document. |
| 101.DEF\*\*\* | XBRL Taxonomy Extension Definition Linkbase Document. |
| 104\*\* | Cover Page Interactive Data File. |

---

\* Filed herewith.

\*\* The XBRL Instance Document and Cover Page Interactive Data File do not appear in the Interactive Data File because their XBRL tags are embedded within the Inline XBRL document.

\*\*\* Submitted electronically with the report.

# Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Company agrees to furnish a copy of all omitted exhibits and schedules to the Securities and Exchange Commission upon its request.

------

<u>[**Table of Contents**](#i058e5e84d872478ab6915372b30916e3_10)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| | **NETSTREIT Corp.** |
| October 27, 2025 | /s/ MARK MANHEIMER |
| Date | Mark Manheimer |
|  | President, Chief Executive Officer, Secretary and Director |
|  | (Principal Executive Officer) |
| October 27, 2025 | /s/ DANIEL DONLAN |
| Date | Daniel Donlan |
|  | Chief Financial Officer and Treasurer |
|  | (Principal Financial Officer) |
| October 27, 2025 | /s/ SOFIA CHERNYLO |
| Date | Sofia Chernylo |
|  | Senior Vice President and Chief Accounting Officer |
|  | (Principal Accounting Officer) |

---

## Exhibit 10.1

![](exhibit101-firstamendmen001.jpg)

Exhibit 10.1 FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT THIS FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this "Amendment") dated as of September 25, 2025, by and among NETSTREIT, L.P., a limited partnership formed under the laws of the State of Delaware (the "Borrower"), NETSTREIT CORP., a Maryland corporation (the "Parent"), each of the Lenders party hereto, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent (together with its successors and assigns, the "Administrative Agent"). WHEREAS, the Borrower, the Parent, the Lenders, the Administrative Agent and certain other parties have entered into that certain Second Amended and Restated Credit Agreement dated as of January 15, 2025 (as in effect immediately prior to the effectiveness of this Amendment, the "Credit Agreement"); and WHEREAS, the Borrower, the Lenders party hereto and the Administrative Agent desire to amend certain provisions of the Credit Agreement on the terms and conditions contained herein; NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the parties hereto, the parties hereto hereby agree as follows: Section 1. Specific Amendments to Credit Agreement. Upon the satisfaction of each of the conditions set forth in Section 2 of this Amendment, the parties hereto agree that the Credit Agreement is amended as follows: (a) Section 1.1 of the Credit Agreement is amended by deleting the term "Term SOFR Adjustment" in its entirety and inserting the following in lieu thereof: "Term SOFR Adjustment" means, for any calculation with respect to a Base Rate Loan or a Term SOFR Loan, a percentage per annum equal to 0.00%. (b) Section 1.1 of the Credit Agreement is further amended by amending and restating the following terms in their entirety to read as follows: "Adjusted Daily Simple SOFR" means, for any day (a "Simple SOFR Rate Day"), a rate per annum equal to the greater of (a) SOFR for the day (such day, a "SOFR Determination Day") that is five (5) U.S. Government Securities Business Days prior to (A) if such Simple SOFR Rate Day is a U.S. Government Securities Business Day, such Simple SOFR Rate Day or (B) if such Simple SOFR Rate Day is not a U.S. Government Securities Business Day, the U.S. Government Securities Business Day immediately preceding such Simple SOFR Rate Day, in each case, as such SOFR is published by the SOFR Administrator on the SOFR Administrator's Website; provided that if by 5:00 p.m. on the second (2nd) U.S. Government Securities Business Day immediately following any SOFR Determination Day, SOFR in respect of such SOFR Determination Day has not been published on the SOFR Administrator's Website and a Benchmark Replacement Date with respect to Adjusted Daily Simple SOFR has not occurred, then SOFR for such SOFR Determination Day will be SOFR as published in respect of the first preceding U.S. Government Securities Business Day for which such SOFR was published on the SOFR Administrator's Website; provided further that SOFR as determined pursuant to this proviso shall be utilized for purposes of calculation of Adjusted Daily Simple SOFR for no more than three (3) consecutive Simple SOFR Rate Days and (b) the Floor. Any

------

![](exhibit101-firstamendmen002.jpg)

- 2 - change in Adjusted Daily Simple SOFR due to a change in SOFR shall be effective from and including the effective date of such change in SOFR without notice to the Borrower. "Eligible Property" means each Property that satisfies the following requirements: (a) such Property is fully developed as a retail or reasonably similar Property; (b) such Property is owned in fee simple, or leased under an Eligible Ground Lease, by the Borrower or a Wholly Owned Subsidiary of the Borrower that is a Guarantor; (c) such Property is located in a State of the United States of America or in the District of Columbia; (d) regardless of whether such Property is owned by the Borrower or a Wholly Owned Subsidiary of the Borrower, the Borrower or such Wholly Owned Subsidiary has the right directly, or indirectly through a Subsidiary, to take the following actions without the need to obtain the consent of any Person: (i) to create Liens on such Property as security for Indebtedness of the Borrower or such Wholly Owned Subsidiary, as applicable, and (ii) to sell, transfer or otherwise dispose of such Property (or in the case of a Property subject to an Eligible Ground Lease, its leasehold interest in such Property); (e) neither such Property, nor if such Property is owned by a Wholly Owned Subsidiary, any of the Borrower's direct or indirect ownership interest in such Wholly Owned Subsidiary, is subject to (i) any Lien other than Permitted Liens or (ii) any Negative Pledge; (f) such Property is not a Development Property; and (g) such Property is free of all structural defects or major architectural deficiencies, title defects, environmental conditions or other adverse matters except for defects, deficiencies, conditions or other matters, in each case which individually or collectively are not material to the operation of such Property in the ordinary course of business. For the avoidance of doubt, no Property owned or leased by an Excluded Subsidiary shall be an "Eligible Property" hereunder. "Interest Expense" means, with respect to a Person and for any period, without duplication, (i) total interest expense of such Person, including capitalized interest not funded under a construction loan interest reserve account, and in any event shall include all interest expense with respect to any Indebtedness of the Parent and its Subsidiaries in respect of which such Person is wholly or partially liable whether pursuant to any repayment, interest carry, performance guarantee or otherwise, determined on a consolidated basis in accordance with GAAP for such period, excluding (ii) non-cash interest expenses incurred in connection with Derivatives Contracts. The Parent's Ownership Share of the Interest Expense of its non-Wholly Owned Subsidiaries and Unconsolidated Affiliates will be included when determining the Interest Expense of the Parent. "Total Asset Value" means, as to any Person as of a given date, the sum (without duplication) of all of the following of such Person and its Subsidiaries determined on a consolidated basis in accordance with GAAP applied on a consistent basis and subject to the Ownership Share Adjustment: (a) Unrestricted Cash and Cash Equivalents; plus (b) the quotient of (i) the Net Operating Income for all Properties of such Person (other than Properties subject to clause (c) below) for the fiscal quarter most recently ended multiplied by four (4), divided by (ii) the Capitalization Rate; plus (c) the GAAP book value as of the date of acquisition of Properties acquired during the then current fiscal quarter and Properties acquired during the immediately preceding two full fiscal quarters; plus (d) the GAAP book value of all Mortgage Receivables (at the value reflected in the Parent's consolidated financial statements in accordance with GAAP, as of such date, including the effect of impairment charges); plus (e) the current GAAP book value of all

------

![](exhibit101-firstamendmen003.jpg)

- 3 - Development Properties; plus (f) the current GAAP book value of Unimproved Land plus (g) the aggregate positive amount of net cash proceeds that would be due to the Parent from all Equity Forward Contracts that have not yet settled as of such date, calculated as if such Equity Forward Contracts were settled by the Parent's delivery of its common shares as of, and such net cash proceeds were actually received on, the last day of the then most recently ended fiscal quarter; provided, that such calculation shall exclude each Equity Forward Contract, if any, with respect to which either (x) the Parent or the counterparty would not reasonably be expected (as determined in good faith by the Parent), for any reason, to be able to fulfill its obligations thereunder prior to the latest Facility Termination Date or (y) the Parent no longer intends to issue shares sufficient to realize such proceeds. Such Person's Ownership Share of assets held by non-Wholly Owned Subsidiaries and Unconsolidated Affiliates (excluding assets of the type described in the immediately preceding clause (a)) will be included in the calculation of Total Asset Value consistent with the above described treatment for wholly-owned assets. Notwithstanding the foregoing, for purposes of determining Total Asset Value, (A) to the extent the amount of Total Asset Value attributable to Properties owned by non-Wholly Owned Subsidiaries and Unconsolidated Affiliates would exceed 10% of the aggregate Total Asset Value at any time, such excess shall be excluded; (B) to the extent the amount of Total Asset Value attributable to Unimproved Land would exceed 5% of the aggregate Total Asset Value at any time, such excess shall be excluded; (C) to the extent the amount of Total Asset Value attributable to Development Properties would exceed 15% of the aggregate Total Asset Value at any time, such excess shall be excluded; (D) to the extent the amount of Total Asset Value attributable to Mortgage Receivables would exceed 10% of the aggregate Total Asset Value at any time, such excess shall be excluded; (E) to the extent the amount of Total Asset Value attributable to Properties leased under an Eligible Ground Lease would exceed 5% of the aggregate Total Asset Value at any time, such excess shall be excluded; and (F) to the extent the aggregate value attributable to the immediately preceding clauses (A), (B), (C), (D) and (E) would exceed 30% of the aggregate Total Asset Value at any time, such excess shall be excluded. "Unencumbered Asset Value" means, as to any Person as of a given date, the sum (without duplication) of all of the following of such Person and its Subsidiaries determined on a consolidated basis in accordance with GAAP applied on a consistent basis: (a) Unrestricted Cash and Cash Equivalents; plus (b) the quotient of (i) the Unencumbered Adjusted NOI (excluding NOI attributable to Development Properties) of such Person (other than Properties subject to clause (c) below) for the fiscal quarter most recently ended multiplied by four (4), divided by (ii) the Capitalization Rate; plus (c) the GAAP book value as of the date of acquisition of Eligible Properties acquired during the then current fiscal quarter and Eligible Properties acquired during the immediately preceding two full fiscal quarters plus (d) the aggregate positive amount of net cash proceeds that would be due to the Parent from all Equity Forward Contracts that have not yet settled as of such date, calculated as if such Equity Forward Contracts were settled by the Parent's delivery of its common shares as of, and such net cash proceeds were actually received on, the last day of the then most recently ended fiscal quarter; provided, that such calculation shall exclude each Equity Forward Contract, if any, with respect to which either (x) the Parent or the counterparty would not reasonably be expected (as determined in good faith by the Parent), for any reason, to be able to fulfill its obligations thereunder prior to the latest Facility Termination Date or (y) the Parent no longer intends to issue shares sufficient to realize such proceeds. Notwithstanding the foregoing, for

------

![](exhibit101-firstamendmen004.jpg)

- 4 - purposes of determining the Unencumbered Asset Value, (A) to the extent the aggregate amount of Unencumbered Asset Value attributable to a single tenant would exceed 15% of the aggregate Unencumbered Asset Value at any time, such excess shall be excluded, (B) to the extent the amount of Unencumbered Asset Value attributable to Eligible Properties leased under an Eligible Ground Lease would exceed 5% of the aggregate Unencumbered Asset Value at any time, such excess shall be excluded and (C) to the extent the aggregate Unencumbered Asset Value attributable to the net cash proceeds that would be due the Parent from Equity Forward Contracts pursuant to clause (d) above would exceed 7.5% of the aggregate Unencumbered Asset Value, at any time, such excess shall be excluded. "Unrestricted Cash and Cash Equivalents" means the aggregate amount of unrestricted cash and Cash Equivalents of the Borrower and its Wholly Owned Subsidiaries (other than Excluded Subsidiaries); provided that (a) Unrestricted Cash and Cash Equivalents shall exclude (i) tenant deposits and (ii) other cash and Cash Equivalents that are subject to a Lien or a Negative Pledge (other than customary rights of set-off and statutory or common law provisions relating to bankers' liens) or the disposition of which is restricted in any way and (b) the parties hereto agree that cash of the Borrower and its Wholly Owned Subsidiaries that is held in escrow in connection with the completion of "like-kind" exchanges being effected in accordance with Section 1031 of the Internal Revenue Code shall not be deemed to be restricted for purposes of this definition. Section 2. Conditions Precedent. The effectiveness of this Amendment is subject to receipt by the Administrative Agent of each of the following, each in form and substance satisfactory to the Administrative Agent: (a) a counterpart of this Amendment duly executed by the Borrower, the Parent, the Administrative Agent and each of the Lenders; and (b) a Guarantor Acknowledgement substantially in the form of Exhibit A attached hereto, executed by each Guarantor. Section 3. Representations. Each of the Borrower and the Parent represents and warrants to the Administrative Agent and the Lenders that: (a) Authorization. Each of the Borrower and the Parent has the right and power, and has taken all necessary action to authorize it, to execute and deliver this Amendment and to perform its obligations hereunder and under the Credit Agreement, as amended by this Amendment, in accordance with their respective terms. This Amendment has been duly executed and delivered by a duly authorized officer of each of the Borrower and the Parent and each of this Amendment and the Credit Agreement, as amended by this Amendment, is a legal, valid and binding obligation of the Borrower and the Parent enforceable against the Borrower and the Parent in accordance with its respective terms except as the same may be limited by bankruptcy, insolvency, and other similar laws affecting the rights of creditors generally and the availability of equitable remedies for the enforcement of certain obligations contained herein or therein and as may be limited by equitable principles generally. (b) Compliance with Laws, etc. The execution and delivery by the Borrower and the Parent of this Amendment and the performance by the Borrower and the Parent of this Amendment and the Credit Agreement, as amended by this Amendment, in accordance with their respective terms, do not and

------

![](exhibit101-firstamendmen005.jpg)

- 5 - will not, by the passage of time, the giving of notice or otherwise: (i) require any Loan Party to obtain a Governmental Approval (other than any required filing with the SEC) or violate any Applicable Law (including all Environmental Laws) relating to the Borrower or any other Loan Party; (ii) conflict with, result in a breach of or constitute a default under the organizational documents of the Borrower, the Parent or any other Loan Party, or any indenture, agreement or other instrument to which the Borrower, the Parent or any other Loan Party is a party or by which it or any of its respective properties may be bound; or (iii) result in or require the creation or imposition of any Lien upon or with respect to any property now owned or hereafter acquired by the Borrower, the Parent or any other Loan Party. (c) No Default. No Default or Event of Default has occurred and is continuing as of the date hereof or will exist immediately after giving effect to this Amendment. Section 4. Reaffirmation of Representations by Borrower. Each of the Borrower and the Parent hereby reaffirms that the representations and warranties made or deemed made by the Borrower, the Parent and each other Loan Party in the Loan Documents to which any of them is a party are true and correct in all material respects (except in the case of a representation or warranty qualified by materiality, in which case such representation or warranty is true and correct in all respects) on and as of the date hereof with the same force and effect as if made on and as of the date hereof except to the extent that such representations and warranties expressly relate solely to an earlier date (in which case such representations and warranties were true and correct in all material respects (except in the case of a representation or warranty qualified by materiality, in which case such representation or warranty was true and correct in all respects) on and as of such earlier date). Section 5. Certain References. Each reference to the Credit Agreement in any of the Loan Documents shall be deemed to be a reference to the Credit Agreement as amended by this Amendment. This Amendment shall constitute a Loan Document. Section 6. Expenses. The Borrower shall pay or reimburse the Administrative Agent for all of its reasonable out-of-pocket costs and expenses (including the reasonable fees and disbursements of counsel to the Administrative Agent) incurred in connection with preparation, negotiation and execution of this Amendment and the other agreements and documents executed and delivered in connection herewith. Section 7. Benefits. This Amendment shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns. Section 8. GOVERNING LAW. THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS EXECUTED, AND TO BE FULLY PERFORMED, IN SUCH STATE. Section 9. Effect. Except as expressly herein amended, the terms and conditions of the Credit Agreement and the other Loan Documents remain in full force and effect. The amendments contained herein shall be deemed to have prospective application only from the date as of which this Amendment is dated, unless otherwise specifically stated herein. Section 10. Counterparts. This Amendment may be executed in any number of counterparts (which may be effectively delivered by facsimile, in portable document format ("PDF") or other similar electronic means), each of which shall be deemed to be an original and shall be binding upon all parties, their successors and assigns.

------

![](exhibit101-firstamendmen006.jpg)

- 6 - Section 11. Definitions. All capitalized terms not otherwise defined herein are used herein with the respective definitions given them in the Credit Agreement. [Signatures on Next Page]

------

![](exhibit101-firstamendmen007.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Second Amended and Restated Credit Agreement to be executed as of the date first above written. NETSTREIT, L.P., as the Borrower By: NETSTREIT GP, LLC, its General Partner By: /s/ Daniel Donlan Name: Daniel Donlan Title: Secretary and Treasurer NETSTREIT CORP., as the Parent By: /s/ Daniel Donlan Name: Daniel Donlan Title: Chief Financial Officer and Treasurer [Signatures Continued on Next Page]

------

![](exhibit101-firstamendmen008.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;[Signature Page to First Amendment to Second Amended and Restated Credit Agreement for NetSTREIT, L.P.] WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent and as a Lender By: /s/ Thomas Dickey Name: Thomas Dickey Title: Vice President [Signatures Continued on Next Page]

------

![](exhibit101-firstamendmen009.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;[Signature Page to First Amendment to Second Amended and Restated Credit Agreement for NetSTREIT, L.P.] BANK OF AMERICA, N.A., as a Lender By: /s/ Roger C. Davis Name: Roger C. Davis Title: Senior Vice President [Signatures Continued on Next Page]

------

![](exhibit101-firstamendmen010.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Signature Page to First Amendment to Second Amended and Restated Credit Agreement for NetSTREIT, L.P.] REGIONS BANK, as a Lender By: /s/ Katie Gifford Name: Katie Gifford Title: Vice President [Signatures Continued on Next Page]

------

![](exhibit101-firstamendmen011.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Signature Page to First Amendment to Second Amended and Restated Credit Agreement for NetSTREIT, L.P.] TD BANK, N.A., as a Lender By: /s/ George Skoufis Name: George Skoufis Title: Vice President [Signatures Continued on Next Page]

------

![](exhibit101-firstamendmen012.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;[Signature Page to First Amendment to Second Amended and Restated Credit Agreement for NetSTREIT, L.P.] ASSOCIATED BANK, NATIONAL ASSOCIATION, as a Lender By: /s/ Mitchell Vega Name: Mitchell Vega Title: Senior Vice President [Signatures Continued on Next Page]

------

![](exhibit101-firstamendmen013.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;[Signature Page to First Amendment to Second Amended and Restated Credit Agreement for NetSTREIT, L.P.] TRUIST BANK, as a Lender By: /s/ Ryan Almond Name: Ryan Almond Title: Director [Signatures Continued on Next Page]

------

![](exhibit101-firstamendmen014.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Signature Page to First Amendment to Second Amended and Restated Credit Agreement for NetSTREIT, L.P.] THE HUNTINGTON NATIONAL BANK, as a Lender By: /s/ Joe White Name: Joe White Title: Senior Vice President [Signatures Continued on Next Page]

------

![](exhibit101-firstamendmen015.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Signature Page to First Amendment to Second Amended and Restated Credit Agreement for NetSTREIT, L.P.] PNC BANK, NATIONAL ASSOCIATION, as a Lender By: /s/ Andrew T. White Name: Andrew T. White Title: Senior Vice President [Signatures Continued on Next Page]

------

![](exhibit101-firstamendmen016.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Signature Page to First Amendment to Second Amended and Restated Credit Agreement for NetSTREIT, L.P.] U.S. BANK NATIONAL ASSOCIATION, as a Lender By: /s/ Travis Myers Name: Travis Myers Title: Senior Vice President [Signatures Continued on Next Page]

------

![](exhibit101-firstamendmen017.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Signature Page to First Amendment to Second Amended and Restated Credit Agreement for NetSTREIT, L.P.] STIFEL BANK & TRUST, as a Lender By: /s/ Jordan Morrison Name: Jordan Morrison Title: Loan Officer

------

## Exhibit 31.1

Exhibit 31.1

**CERTIFICATION**

I, Mark Manheimer, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of NETSTREIT Corp.;

2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) &nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

------

---

| | | | |
|:---|:---|:---|:---|
| Date: | October 27, 2025 | By: | /s/ MARK MANHEIMER |
|  |  |  | Mark Manheimer |
|  |  |  | President, Chief Executive Officer and Secretary |

---

## Exhibit 31.2

Exhibit 31.2

**CERTIFICATION**

I, Daniel Donlan, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of NETSTREIT Corp.;

2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) &nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

------

---

| | | | |
|:---|:---|:---|:---|
| Date: | October 27, 2025 | By: | /s/ DANIEL DONLAN |
|  |  |  | Daniel Donlan |
|  |  |  | Chief Financial Officer and Treasurer |

---

## Exhibit 32.1

Exhibit 32.1

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with this Quarterly Report on Form 10-Q of NETSTREIT Corp. (the "Company") for the period ended September 30, 2025, as filed with the Securities and Exchange Commission (the "Report"), the undersigned, as the President, Chief Executive Officer, Secretary and Director of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | | |
|:---|:---|:---|:---|
| Date: | October 27, 2025 | Signed: | /s/ MARK MANHEIMER |
| | | | Mark Manheimer |
| | | | President, Chief Executive Officer and Secretary |

---

This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

## Exhibit 32.2

Exhibit 32.2

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with this Quarterly Report on Form 10-Q of NETSTREIT Corp. (the "Company") for the period ended September 30, 2025, as filed with the Securities and Exchange Commission (the "Report"), the undersigned, as the Chief Financial Officer and Treasurer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | | |
|:---|:---|:---|:---|
| Date: | October 27, 2025 | Signed: | /s/ DANIEL DONLAN |
| | | | Daniel Donlan |
| | | | Chief Financial Officer and Treasurer |

---

This certification accompanies the Report to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

<br>